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The Sec 18 protein (Secl8p) of the yeast Saccharomyces cerevisiae has been identified as a
component involved in the vesicular transport of proteins through the secretory and endocytotic
pathways. Secl8p is a homologue of the mammalian protein NSF which has been shown, using a
number of in vitro transport assay systems and affinity purification procedures, to interact with other
proteins in a multisubunit protein complex. This complex is thought to mediate the fusion of a
specific transport vesicle with its respective target membrane allowing the specific targeting of a cargo
protein to its final destination. A genetic interaction has been demonstrated between SEC18 and
SEC17 (encoding the homologue of mammalian a - SNAP) and a number of SNAP receptors have
recently been isolated from bovine brain cytosol but no direct interaction has been demonstrated
betweeen Secl8p/Secl7p and these proteins within a yeast system.
This work represents two approaches taken with the aim of identifying proteins that interact with
Secl8p in the yeast Saccharomyces cerevisiae. Isolation of protein complexes was first attempted by
affinity purification of a tagged version of Secl8p. The protein was C-terminally tagged with a
protein A moiety from Staphylococcus aureus containing IgG binding domains. It was hoped that the
affinity of protein A for IgG Sepharose could be used to isolate protein complexes that formed in
vivo with the Secl8p. Although the fusion construct was shown to be active in vivo, specific
complexing proteins could not be isolated due to the large amount of non-specific binding of yeast
proteins to the protein A moiety.
A second genetical approach was used where the SEC18 gene was randomly mutagenised and yeast
cells harbouring these mutagenized genes were screened for a dominant negative phenotype.
Dominant negative mutant forms of the Secl8p interfere with the normal function of the wild-type
protein in vivo. Five such mutants were isolated and classified into two main groups using a number
of biochemical and morphological criteria. Class I mutants show a classical secretory mutant
phenotype whereas the Class II mutant has a novel phenotype. A number of mutants in which the
dominant negative phenotype was suppressed were isolated but the genes responsible for this
phenotype could not be identified. It is hoped that alternative strategies can be employed in the future
to identify extragenic suppressors of these mutants.
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Most proteins in eukaryotic cells are synthesised in the cytosol but their final site of
action may be within a number of organelles such as the lysosome (vacuole in yeast
cells), the plasma membrane or the external environment (Palade et al., 1975).
Proteins destined for sites other than the cytosol, mitochondria or peroxisome are
initially cotranslationally translocated across the endoplasmic reticulum (ER) and are
transported through a series of membrane-bound compartments, undergoing
successive modifications before they are targeted to their final point of action. How
do proteins become targeted to this biosynthetic pathway ?
1.1.1 Targeting of proteins to the endoplasmic reticulum (ER)
Early work identified specific signal sequences at the N-terminus of a number of
nascent polypeptide chains and these were found to consist of a very hydrophobic
sequence of 15-30 amino acids (von Heijne et al., 1985). For most proteins destined
to be secreted from the cell or for the lysosome the signal sequence is cleaved off once
the proteins are in the lumen of the ER, whereas in membrane proteins this signal
sequence often acts as a membrane anchor and remains intact within the protein.
Mammalian cell-free assay systems which reproduced the targeting and translocation
of proteins across the ER membrane led to the isolation of a signal recognition particle
(SRP) (Walter and Blobel, 1980) and its receptor (Gilmore et al., 1982a & b). The
function of these proteins in the translocation process was shown using cell-free
translation systems in which the exact fate of the nascent polypeptides could be
followed.
Mammalian SRP (an 1 IS cytoplasmic ribonucleoprotein containing six polypeptides
of 72, 68, 54, 19, 14 and 9kDa together with one 7SL RNA molecule) was purified
from canine pancreas by following its translocating-promoting activity in a
heterologous in vitro system. The particle has been shown to cycle between cytosolic
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and membrane-bound forms and is attributed three main functions in vivo : (1) the
54kDa subunit binds the signal sequence on nascent polypeptide chains via a
methionine-rich (M domain) region in a GTP-dependent manner (Bernstein et al.,
1989; High et al., 1991; Zopf et al., 1990). Although the M domain (SRP54M) is
sufficient for binding signal sequences in the absence of the GTP binding domain (G
domain), chemical modifications of the G domain blocked binding implying that this
region was involved in the regulation of the binding of signal sequences (Lutcke et
al., 1992). (2) Binding of the SRP to the signal sequence inhibits translation as seen
in vitro possibly allowing time for the movement and targeting of the ribosomal
complex to the ER membrane where (3) the SRP binds to the SRP receptor, a
heterodimeric protein (SRa and SRP) found anchored in the ER membrane. The
nature of the interaction of the SRP G domain with both SRa and SRP subunits
(which both have GTPase activities) is not known but the hydrolysis of GTP may in
some way stimulate the dissociation of SRP and release the translational block on the
nascent polypeptide (for review see Rapoport, 1991), resulting in translocation of the
nascent chain.
1.1.2 Translocation of proteins into the ER
Once targeted to the ER how do proteins cross the membrane bilayer ? Protease
protection assays have implicated the presence of proteins in the ER membrane which
have been postulated to form a protein 'translocon' that is required for this
translocation process across the lipid bilayer (Connolly et al., 1989). Incorporation of
photoreactive chemical groups into nascent polypeptide chains has allowed the cross-
linking of these polypeptides to neighbouring proteins in the ER membrane bilayer. In
this way a number of protein components of the translocon have been identified e.g
ribophorins, a 35-39kD protein, translocating chain associated membrane protein
(Gorlich et al., 1992) and a 205kD protein with an as yet unknown function
(Anderson and Denny, 1992). The actual mechanisms involved in the translocation of
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proteins across the ER membrane are still not fully understood.
A number of yeast mutants were isolated which are defective in the translocation of
soluble proteins into the ER lumen (sec61, 62 and 63); (Stirling et al., 1992). The
isolation of such mutants has allowed the examination of protein translocation
efficiencies in vivo. Chemical crosslinking studies have shown that the protein
products of these genes interact in a large complex with a further two unidentified
proteins (Deshaies et al., 1991). The translocation of soluble proteins such as a-
factor precursor or carboxypeptidase Y (CPY) precursor were shown to be blocked in
single or double combinations of mutants sec61,62 and 63. However, other proteins
such as invertase or the vacuolar membrane protein dipeptidylaminopeptidase B
(DPAPB) were affected to a lesser extent. A stricter genetic screen was employed to
try and isolate mutants that were defective in the translocation of membrane proteins; a
new mutant allele of sec61 was isolated and a further new gene identified (SEC65) the
gene product of which is homologous to the 19kDa mammalian SRP subunit (Hann
et al., 1992; Stirling and Hewitt, 1992). Yeast homologues of both the 54kDa subunit
of SRP (SRP54) and the 7SL RNA (scRl) have been identified (Hann and Walter,
1991) as well as a receptor for SRP (Ogg et al., 1992). Surprisingly, deletion
mutants of both the SRP and the SRP receptor have shown that these proteins
although important for cell growth and secretion are not essential. In fact mutants that
are left long enough undergo physiological changes which allow them to overcome
these deficiences and start to secrete and grow once more.
The translocation efficiency across the ER membrane for a range of proteins was
monitored in mutants which had a loss of SRP or SRP receptor function.
Surprisingly, the efficiencies of translocation were dependent on the type of protein
monitored. Translocation of Kar2p (the yeast homologue of BiP) and DPAPB was
severely disrupted whereas translocation of a-factor precursor protein was disrupted
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to a lesser extent. The efficiency of CPY translocation into the ER was not affected in
these mutants. These observations are of the inverse to those observed in the sec61,
62 and 63 secretory mutants although the significance of this relationship is as yet
unknown.
However, in both groups of mutants discussed a large variation in translocation
phenotype is observed for different proteins which suggests that a variety of
translocation pathways exist within eukaryotic cells that allow the insertion of proteins
into or through the ER membrane bilayer. The most efficient pathway is the SRP-
dependent cotranslational translocation of proteins into the ER (observed for DPAPB
and Kar2p) but proteins may be inserted either posttranslationally (possibly in the case
of a-factor precursor protein) in an hsp70/chaperone dependent manner or by a
cotranslational SRP independent pathway (possibly in the case of CPY protein).
Although the alternative pathways could explain the results seen in the mutant yeast
cells these may represent minor salvage pathways which are used in stressed
situations and may not represent the major route taken for the translocation of proteins
within a wild-type yeast cell.
1.1.3 Processing of proteins within the ER
During the translation/translocation process nascent polypeptide chains are acted upon
by a number ofmodifying enzymes resident in the lumen of the ER such as the
molecular chaperone BiP (Kar2p in yeast), signal peptidase and a protein disulphide
isomerase (for review see Gething and Sambrook, 1992). Nascent polypeptides enter
the lumen of the ER in an extended configuration exposing hydrophobic regions that
are normally hidden in the folded conformation of a mature protein. The molecular
chaperone BiP (an ATPase) is thought to bind these polypeptides to mask/exposed
regions and thus prevent protein aggregation and allow correct protein folding to
occur. This has been corroborated by crosslinking studies within yeast cells in which
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proteins trapped in the process of translocation were found to be crosslinked to
Sec61p and BiP/Kar2p (Sanders et al., 1992).
Most secretory proteins are glycoproteins and in yeast are generally mannoproteins
containing N-and O-linked carbohydrate moieties. Synthesis of such N-linked
glycosylation occurs during protein translocation through the ER in a similar way in
both yeast and mammalian cells. A 'core' oligosaccharide (GlcNAc)2-Man9-GlC3 is
transferred in a single step from a dolichol-phosphate carrier to Asn residues on the
nascent protein to give N-glycosidic linkages. The glucose (Glc3) residues are then
trimmed off before the protein is transported to the Golgi.
1.1.4 Processing of proteins within the Golgi apparatus
In mammalian cells as a glycoprotein is transported through the Golgi apparatus it is
processed by a series of mannosidases and sugar transferases to give a final complex
structure containing Man, plus additional GlcNAc, galactose, fucose and sialic acid
residues. The distribution of the specific enzyme(s) responsible for this series of
processing events has been elucidated using immunolocalization and subcellular
fractionation techniques and has demonstrated that the mammalian Golgi complex is
divided into at least three spatially and functionally distinct regions: cis Golgi network
(CGN), medial, and trans Golgi network (TGN), (for review see Dunphy and
Rothman, 1985). These regions can be morphologically defined as distinct stacked
Golgi cisternae (for review see Mellman and Simons, 1992).
The compartmental organization of the Golgi complex within yeast cells however has
not been extensively characterized. The fission yeast Schizosaccharomyces pombe
has a Golgi complex morphologically similar to that ofmammalian cells (Chappell and
Warren, 1989) however, stacked Golgi cisternae are rarely seen within the wild-type
budding yeast, S. cerevisiae. Stacked and exaggerated Golgi cisternae have been
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observed within two temperature sensitive secretory mutant cells. (sec7 and sec14) in
which there is a block in protein traffic through the Golgi at the restrictive temperature
(Esmon et al., 1981; Stevens et al., 1982) however this may not represent the wild-
type situation. The characterization of the Golgi complex within S. cerevisiae has
been achieved by following the processing events of specific glycoproteins (a-factor
(af), carboxypeptidase Y (CPY), invertase and acid phosphatase) within sec mutants
both at the permissive and restrictive temperature, so defining distinct Golgi
compartments (Stevens et al., 1982).
The pro-af-polypeptide contains four repeated copies of the mature 13 amino acid
peptide (Kurjan and Herskowitz, 1982) which are excised from the precursor in the
Golgi complex by the concerted action of Kex2 endopeptidase (Kex2p), Kexl
carboxypeptidase and dipeptidylaminopeptidase A (Stel3p) (Bussey, 1988; Fuller et
al., 1988). Enzyme(s) that catalyse a 1,6 Man addition have been localised to an early
Golgi compartment that lacks a 1,3 and Kex2 protease activities (Franzusoff and
Schekman, 1989). In addition membranes enriched for a 1,3 mannosyltransferase
and Kex2 protease activities can be partially separated within Percoll gradients
(Cunningham and Wickner, 1989).
From such studies three functionally distinct compartments have been defined in the
Golgi apparatus of the yeast S. cerevisiae . Proteins transported from the ER first
pass through a compartment in which the glycoproteins are extended by an al,6
mannosyl transferase . This compartment may be the equivalent of the CGN or
represent an early compartment of the medial Golgi. In a further medial Golgi
compartment the glycoproteins are modified by a 1,2 and a 1,3 mannosyltransferases,
after which these proteins are transported to the functional equivalent of the
mammalian TGN which contains a set of proteolytic enzymes: Kex2p, Kexlp and
DPAP A which act on the af pheromone (Bryant and Boyd, 1993). This
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compartment also seems to represent the site where vacuolar proteins (e.g. CPY) are
sorted and directed to their final destinations (Graham and Emr, 1991) (see Figure
1.1.).
Indirect immunofluorescence staining with antibodies directed against Golgi proteins,
such as Kex2p, Kexlp and DPAP A give a pattern of dispersed patches (Redding et
al., 1991) and immunoelectron microscopy has shown the presence of disc-like
membranes dispersed throughout the cytoplasm (Preuss et al., 1992). Thus, although
the yeast and mammalian Golgi apparatus seem to be functionally similar they may not
be spatially organised in the same way.
Proteins destined for secretion or for intracellular organelles progress through a
number ofmembrane bound compartments in a constant flow ofmembrane transport
vesicles. How does the cell ensure efficient sorting of exported proteins and resident
organellar proteins ? Mutational analysis of resident soluble ER proteins identified a
carboxy-terminal tetrapeptide KDELwhich was shown to be both necessary and
sufficient for the retention of at least one of these proteins (BiP) in the ER (Munro and
Pelham, 1987). In the yeast S. cerevisiae the carboxy-terminal sequence HDEL has
been shown to be sufficient for resident ER protein retention (Pelham et al., 1988).
How are these retention signals recognised by the cell ? Studies involving a KDEL-
tagged peptide revealed that this peptide was subject to post-ER processing although
retained within the ER (Pelham, 1988). This was confirmed in a yeast system by
showing that fusion proteins (pro-a-factor and invertase) bearing C-terminal HDEL
tags accumulated internally, whereas the corresponding protein which lacked this tag
was rapidly processed and secreted from the cell. Fractionation analysis of these cells
confirmed that the accumulated protein was in the ER but had been modified by the
addition of a 1,6 Man residues, a reaction that is thought to occur in an early Golgi
compartment (Kukuruzinska et al., 1987). Retention of such Golgi-modified species
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Figure 1.1 Processing of a-factor and carboxypeptidase Y through
the secretory pathway
This diagram represents a summary of the processing of two glycoproteins that occurs
as they transverse the Golgi apparatus as defined within the secl8-l mutant cells
(Graham and Emr, 1991). CPY is synthesised as a proenzyme and acquires core
oligosaccharides in the ER (the pi form of CPY). The oligosaccharides are then
extended through the medial and TGN (the p2 form ofCPY) until it is sorted from the
TGN via the endosome to the vacuole where it undergoes proteolytic cleavage by
proteinase A and proteinase B (to give the mature form; mCPY).
Pro-a-factor (the precursor form of a-factor) also undergoes core glycosylation and
oligosaccharide extensions within the ER and Golgi apparatus respectively.
Proteolytic cleavage occurs in the TGN by the concerted action of Kex2p, Kexlp and
DPAP A to produce the mature a-factor that is sorted into vesicles and secreted from
the cell.













in the ER is dependent on a receptor-mediated recycling event since overexpression of
HDEL fusion constructs leads to saturation of the system with concomitant secretion
(Dean and Pelham, 1990). This receptor is encoded by the ERD2 gene in S.
cerevisiae (Semenza et al., 1990) and the human homologue of this receptor has also
been identified (Lewis and Pelham, 1990).
In addition to the recycling of resident proteins to the ER, proteins are held back
within the ER until they are in the correct conformation before further transport
through the secretory pathway. Mutants of haemagglutinin which block various
stages of the protein folding pathway were unable to exit from the ER and were found
to be bound to BiP (Gething et al., 1986). It seems that unfolded proteins are retained
transiently in the ER by the action of the chaperone BiP which binds to nascent
polypeptide chains until the correct folding is observed.
1.1.5 Bulk flow of proteins through the secretory pathway
The presence of these organelle specific retention signals has led to a model in which
proteins lacking a specific retention sequence are moved from the ER in the lumen and
walls of unselective transport vesicles in a rapid 'bulk flow' process and are finally
secreted from the cell. Only proteins that contain specific retention signals are held
back or targeted to specific organelles e.g the cis face of the Golgi is thought to be a
salvage compartment and is the main site of recognition and recycling of escaped ER
resident proteins. Studies within CHO cells using signal-less tripeptides with acceptor
sites for glycosylation showed that these peptides were glycosylated in the ER and
secreted efficiently from the cells (Wieland et al., 1987). However, recent analysis
within S. cerevisiae has shown that peptide export from the ER is not inhibited by
antibodies against proteins involved in formation of transport vesicles, the peptides do
not reside in membrane bound vesicles after export and they do not receive Golgi
specific modifications. This suggests that the exit route for tripeptides is different
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from that of secreted proteins (Romisch and Schekman, 1992). Mutational analysis of
Golgi integral membrane proteins has shown their mislocalization to the vacuole and
not to the plasma membrane suggesting that there could be a different default pathway
for membrane proteins within the cell (Cooper and Bussey, 1992; Roberts et al.,
1992).
Because so many transport steps require vesicle intermediates the understanding of the
common mechanisms underlying vesicle formation, targeting and fusion are very
important. A great deal of progress has been made in the past three years in the
identification of a number of components that are involved in vesicle fusion events that
occur throughout the secretory pathway of both mammalian cells using a variety of in
vitro transport assays and in the yeast S. cerevisiae by the isolation of a number of
secretory mutants.
1.1.6 Secretory mutants of Saccharomyces cerevisiae
The yeast S. cerevisiae has been shown to have a secretory pathway similar to that
seen in mammalian cells which allows the use of a number of genetic techniques to
study this process. An initial observation that a mutant yeast strain defective in
growth at the restrictive temperature of 37°C had an increased density compared with
a wild-type yeast strain on sucrose gradients (Novick and Schekman, 1979) led to a
density enrichment screen of chemically mutagenised cells at 37°C to isolate
temperature sensitive (ts) secretory (sec) mutants. A number of mutants isolated in this
way showed a block in export of cell surface-associated proteins (invertase and acid
phosphatase) and were classified into three main groups: Class A mutants accumulated
invertase internally at the restrictive temperature; Class B mutants had no invertase
accumulation although protein synthesis still occurred at the restrictive temperature;
and Class C mutants exhibited temperature sensitive protein synthesis.
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Morphological analysis of Class A mutants revealed that they accumulated one of
three distinct organelle structures depending on the position at which the secretory
pathway was blocked e.g. endoplasmic reticulum (ER), Golgi-like structures called
Berkeley bodies and 80-100 nm secretory vesicles representing transport intermediates
en route to the plasma membrane. Genetic analysis of these mutants identified 23
complementation groups {seel-23) acting throughout the secretory pathway indicating
that at least 23 independent gene products are involved in the export of proteins from
the cell (Novick et al., 1980). Two additional mutants betl and bet2 (blocked in early
transport) were isolated using a [3H] mannose suicide selection in which cells
defective in protein transport to the Golgi apparatus do not receive lethal mannose
additions to their glycoproteins (Newman and Ferro-Novick, 1987).
Genes which have an effect in independent pathways that contribute to the same
process show both the single mutant phenotypes in a double mutant whereas genes
that act in the same pathway exhibit the phenotype of the earliest acting mutant in a
double mutant. The construction of double sec mutants allowed the position at which
these genes act within the pathway to be identified thus dissecting the pathway into
three main stages (a) Early ER to Golgi transport requiring at least nine sec gene
products (b) Packaging of proteins from the late Golgi into secretory vesicles in an
energy-dependent manner and (d) secretory vesicle to plasma membrane transport
(Novick et al., 1981).
Further morphological and genetical analysis has been employed to dissect early ER to
Golgi transport (Kaiser and Schekman, 1990). Of the nine sec mutants acting at this
stage three Class II mutants {sec 17, 18, and 22 ) accumulate an extended ER and 50
nm vesicles. Histochemical staining of a cargo protein within these mutants suggests
that the 50 nm vesicles are ER-derived. Formation of such vesicles is not seen in the
Class I mutants (sec 12, 13, 16, and 23 ) at the restrictive temperature. Double
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mutant analysis of Class I/Class II mutant combinations suggests that the early sec
mutants can be sub-divided into functions of vesicle formation (Class I mutants) and
vesicle fusion (Class II mutants) functions, sec17,18 double mutants exhibit synthetic
lethality (i.e double mutants are lethal at the permissive temperature 24°C) which has
been taken to imply an interaction of these gene products at the same biochemical step
during intermediate vesicle fusion to the cis Golgi apparatus. Since transport from the
ER precedes other events in secretion no step after this stage in the exocytotic pathway
may be monitored genetically and so these genes may act at multiple stages of the
secretory pathway.
Analysis of fluid-phase endocytosis in yeast was carried out by measuring the uptake
of a fluorescent dye into the vacuole of the cell and showed that most of the early
acting sec mutants are not defective in endocytosis at 37°C (Riezman, 1985).
However both sec!8 and sec23 mutant alleles seemed to be defective in endocytosis at
the restrictive temperature implying that both of these gene products also act later in
the secretory pathway or in the endocytotic pathway. In contrast to these results all the
late-acting sec mutants were blocked in the endocytotic pathway also at the restrictive
temperature. This suggests two possible models of the interaction between the
secretory and endocytotic pathways in yeast. Either part of the endocytotic and
secretory pathways are coupled therefore a late block in secretion would block
endocytosis and an early one would not, or the two pathways are separate but share
common gene products.
1.2 Intracellular membrane traffic
1.2.1 Cell free transport systems
The use of an in vitro transport system simulating intra-Golgi transport between the
cis and medial Golgi compartments has led to the identification of proteins involved in
vesicle fusion events within a mammalian cell free system (Balch et al., 1984; Braell
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et al., 1984). This system relies on the incubation of a 'donor' membrane fraction
with a biochemically distinct 'acceptor' fraction and transport is monitored by the
transfer of the cargo protein VSV-G (vesicular somatitis virus G protein) between
these fractions. This protein is a viral outer membrane glycoprotein which is modified
when in the Golgi compartment by the addition of GlcNAc residues. The two
populations of Golgi membranes are isolated from Chinese Hamster Ovary (CHO)
cells and distinguished in that the 'donor' population is isolated from mutant 15B-
CHO cells infected with VSV-G protein. These mutant cells are defective in the
enzyme V-acylglucosaminyl transferase I (normally resident in the medial Golgi) and
so cannot transfer an V-acylglucosamine group from UDP-GlcNAc to the cargo VSV-
G protein. The acceptor population is prepared from wild-type CHO cell population
not infected with VSV-G protein. Co-incubation of these two membrane preparations
results in the transfer of VSV-G protein from the donor to the acceptor compartment
where it will receive a [3H]-UDP-GlcNAc moiety due to the presence ofGlcNAc
transferase I in the wild-type acceptor population. The amount of label found in the
acceptor population is therefore a measure of the vesicular transport that has occurred
between these two compartments. Using this system it was found that there were a
number of requirements for transport, such as the presence of an ATP regenerating
system, fatty acyl CoA (Pfanner et al., 1990), physiological conditions of temperature
and pH, and soluble proteins present in a high speed supernatant fraction obtained
from CHO cells (termed cytosol). Cytosol fractions prepared from other sources such
as bovine brain, and wild-type yeast cells could also substitute for CHO cell cytosol.
Inter-cisternal Golgi transport using this in vitro system could be sub-divided into a
number of intermediary stages using a variety of inhibitors (Orci et al., 1989). The
stages of vesicular transport can be divided into the initial budding of vesicles from the
donor membrane to produce transport intermediates which are surrounded by a non-
clathrin coat and accumulate in vitro when transport is arrested using GTPy S (a non-
14
hydrolysable analogue of GTP) or AIF4" These coated vesicles are then targeted to
the acceptor membrane where they attach and are uncoated ready for bilayer fusion to
occur. Transport is inhibited by incubating the membranes on ice with a low
concentration (1 mM) of the sulphydryl reagent A-ethylmaleimide (NEM). This
substance arrests transport producing vesicles attached to acceptor membranes in an
uncoated state ready for fusion .
The use of two stage incubations within this cell-free assay system revealed three
intermediate stages in vesicular transport that seemed to correspond to the initial
budding of transport vesicles from the donor membrane and subsequent maturation of
that intermediate vesicle through a prefusion complex leading to final membrane
fusion (Balch etai, 1984; Wattenberg etal., 1986). In the first stage, the donor
membrane is 'primed' and buds off to form an early primed donor intermediate in the
absence of acceptor Golgi membranes. This stage requires the presence of ATP and
cytosol and is sensitive to NEM. The second stage involves the production of a
prefusion intermediate that is dependent on the presence of the acceptor membrane and
therefore represents the attachment of the 'primed' donor vesicle to this membrane.
This low cytosol requiring intermediate (LCRI) was identified by the requirement of a
high concentration of cytosol for its formation whereas its consumption is less
dependent on cytosol. Subsequent maturation of this LCRI occurs in an ATP and
cytosol dependent manner to produce an NEM- resistant prefusion intermediate and
then fusion.
Preliminary fractionation studies of bovine brain cytosol revealed that a distinct
cytosolic component was required to consume this LCRI complex. This protein
(Factor B) has an apparent molecular mass of 25 kDa and is inactive in the priming
stage of vesicular transport (Wattenberg and Rothman, 1986). A similar protein of
25kDa was isolated from the yeast S. cerevisiae and and termed protein operating in
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prefusion (POP).
Molecular cloning of POP revealed it to encode uridine monophosphokinase
(UMPkinase). The cell-free assay system measuring protein transport between
compartments of the Golgi follows the glycosylation of a glycoprotein, G protein (as
described earlier). Glycosylation within this system was assumed to occur
immediately on fusion of the vesicles and therefore this model takes the kinetics of
glycosylation to reflect those of vesicle fusion. However, Golgi uptake of UDP-
GlcNAc was shown to be enhanced in the presence of UMPkinase, leading to an
increased glycosylation signal and thus a false assessment of vesicle fusion.
Reinterpretation of the data revealed that the original kinetic analysis of vesicle traffic
within this system was not correct and the LCRI did in fact represent the vesicle
fusion event (Hiebsch and Wattenberg, 1992). This study highlighed the limitations
that are imposed upon a system when using in vitro analysis.
1.2.2 NEM sensitive factor (NSF)
An NEM sensitive factor (NSF) was identified within CHO cell cytosol by its ability
to restore intracisternal transport within an NEM-inhibited in vitro transport system
and was purified from this cytosol in the presence of ATP (Block et al., 1988). The
purified protein was partially sequenced and this sequence was used to create
degenerate oligonucleotides to clone the full length cDNA sequence. NSF is a
homotetramer consisting of 76kDa subunits and is a soluble protein which
peripherally associates with membranes (Wilson et al., 1989). At which point in
vesicle transport does NSF act ?
Using the previously defined in vitro assay system for vesicular transport a number of
preincubation experiments revealed that NSF was required for vesicle fusion rather
than budding (Malhotra et al., 1988). In the absence of NSF nearly twice the number
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of intermediate vesicles accumulate during cell-free preparations and under the electron
microscope these vesicles are seen to be uncoated suggesting that they have already
uncoated and docked on the acceptor membrane before NSF is required. Specifically
it was shown that NSF is required to form the prefusion LCRI complex in the
presence of ATP. From this it seems that NSF is not an actual 'fusogen' but is
involved with a number of other cytosolic (such as Factor B) and membrane factors to
form a multimeric complex that promotes bilayer fusion.
NSF activity is stabilised in in vitro transport assays by the presence of ATP, and it
has been shown that NSF contains two distinct but homologous ATP-binding
domains and has a low ATPase activity (Wilson et al., 1989; Tagaya et al., 1993)
which although lower than other ATPases, (eg, it is about 50 fold lower than that of
chromaffin granule ATPase) is comparable to that of p97 (Peters et al., 1990). Both
NSF and p97 have been proposed to be members of a novel ATPase family (Erdmann
et al., 1991). A semi-intact CHO cell system prepared from VSV-infected CHO cells
which reconstitutes ER to cis Golgi transport has shown that NSF is also required at
this stage for fusion of the intermediate vesicle with a target membrane to occur
(Beckers et al., 1989). This transport was inhibited both by NEM and a monoclonal
antibody against NSF. Is NSF also implicated in the endocytotic pathway of
eukaryotic cells ? Endocytosis of externally located ligands may be monitored using
two synthetic substances that when internalized and delivered to the same cellular
compartment form a measurable complex. Fusion of early endocytotic vesicles were
shown in this way to require NSF as an essential component (Diaz et al., 1989).
Although most of these kinetic studies suggest NSF is involved in the formation of a
prefusion complex once vesicle attachment has occurred, studies using the antimalarial
drug primaquine, an inhibitor of bud emergence, in a modified in vitro Golgi transport
systems has indicated an earlier role for NSF during the formation of functionally
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active intermediate transport vesicles (Wattenburg et al., 1992).
The ubiquitous nature of NSF within both the secretory and endocytotic transport
pathways seems to suggest that NSF is predominantly involved in a general
mechanism that allows fusion of membrane bilayers to occur. It seems unlikely that
NSF is involved in the specificity observed in vesicle fusions; presumably other
proteins may confer such a role. Reassociation of purified NSF with treated Golgi
membranes in vitro was shown to require an integral membrane receptor and a crude
cytosol fraction containing an NSF attachment protein(s) (Weidman et al., 1989).
Binding of NSF is saturable both with respect to the integral membrane protein and to
the component(s) of the cytosol fraction.
1.2.3 Soluble NSF attachment proteins (SNAP)
In vitro transport between Golgi membranes is arrested when the Golgi membranes
are pretreated with KC1 (KGolgi) which removes all peripherally-associated proteins.
Transport was restored by a bovine brain cytosol preparation. This cytosol was
resolved into three separate pools by gel permeation chromatography (a) NSF fraction
(b) Fr 1 and (c) Fr 2. Fr 2 contained three proteins of related size termed a (35kDa),
(3 (36kDa), and y (39kDa) soluble NSF attachment proteins (SNAP) from their ability
to bind NSF to Golgi membranes (Clary et al., 1990).
Individual SNAPs were purified from the Fr2 fraction of bovine brain cytosol and it
was shown that each SNAP in addition to having a transport activity could bind NSF
independently to the Golgi membrane. SNAP activity was shown to be needed at a
similar stage in vesicle transport as NSF. Does each SNAP interact differently with
NSF in binding to Golgi membranes? In vitro binding studies have revealed that the
SNAP/NSF interaction does not occur in solution but only in the presence of Golgi
membranes (or an artificial solid support). Both a/(3 and y SNAP bind to Golgi
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membranes at distinct binding sites which are integral membrane proteins that are
either within the same polypeptide chain or are separate proteins that are within a tight
complex. NSF will only bind Golgi membranes which have already been 'primed' by
SNAP binding. Although only one SNAP is sufficient for NSF binding, when both
binding sites are filled NSF binds and forms a stable NSF-SNAP complex which may
then mediate vesicle fusions. Initial crosslinking studies have revealed an a-SNAP
receptor (30-40 kDa) within Golgi membranes and a physical interaction between
NSF and a-SNAP has been demonstrated by such crosslinking studies (Whiteheart
et al., 1992). The binding of both a-SNAP and y-SNAP to Golgi membranes was
not affected by Mg++/ATP within these studies but NSF has been shown to dissociate
from Golgi membranes on ATP hydrolysis which suggests that the NSF-SNAP
interaction is being affected rather than the initial SNAP binding.
Recent cloning and sequencing of the cDNAs for a, {3 and y SNAP has allowed the
expression of recombinant proteins for use in cell free transport assays, a and y
SNAP were found to act synergistically in such intra-Golgi transport systems when
the amount of NSF was in excess. Crosslinking studies have shown a direct
interaction between a and y SNAP and both are in contact with NSF and although y
SNAP is not essential for cell-free transport it is thought to stabilise interactions within
the fusion complex. P SNAP seems to be a brain-specific isoform possibly
specialised in certain types of neurosecretion events (Whiteheart et al., 1993).
1.2.4 Evolutionary conservation
Isolation and characterization of proteins involved in mammalian vesicle fusion has led
to the identification of homologous proteins within yeast previously defined by
temperature sensitive sec mutants which show a block in secretion at the
nonpermissive temperature of 37°C. The amino acid sequence of NSF and Secl8p
are 48% identical and they both contain two predicted ATP binding sites. However,
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in vitro translation studies of the SEC18 gene revealed two gene products of 82kDa
and 84 kDa in contrast to the single 76kDa NSF protein within mammalian cells. The
two isoforms of Secl8p may have different functional roles in vivo but their
significance awaits further mutational analysis to test their individual function within
cell-free assay systems. Biochemically, wild-type yeast cytosol has been shown to
have NSF activity, by its ability to restore transport to NEM-treated membranes in a
CHO cell in vitro transport system. This NSF activity in yeast cytosol is inactivated in
the absence of ATP and is NEM sensitive (Wilson et al., 1989). The SEC18 gene
was originally isolated by its ability to complement a secl8-l ts mutation that blocked
transport of proteins between the ER and Golgi apparatus (Eakle et al., 1988). Yeast
cytosol from such a mutant grown at either the permissive temperature of 25°C or the
nonpermissive temperature of 37°C does not contain NSF activity, directly implicating
the Secl8p as the yeast homologue of NSF to be involved in vesicle fusion events.
However, experiments using a broken yeast cell assay system which measures
transport from the ER to the cis Golgi supports the role of Secl8p in a vesicle
attachment event (Rexach and Schekman, 1991). On comparison of the primary
amino acid sequences both NSF and the SEC18 gene product have shown homologies
to a family of ATPase proteins. This family encompasses many diverse cellular
proteins such as the yeast cell cycle protein Cdc48p, the Paslp protein involved in
peroxisome biogenesis and p97 from Xenopus laevis oocytes.(Frohlich et al., 1991;
Erdmann et al., 1991; Peters et al., 1990).
It has been observed that another yeast mutant, the sec17-1 ts mutant, also blocked in
ER to Golgi transport in vivo at the nonpermissive temperature, and that a
secl8-l/secl7-l double mutant showed synthetic lethality. Cytosol prepared from a
sec17-1 mutant is deficient in SNAP activity, shown by its arresting the in vitro
transport system and this cytosol can be complemented by the addition of pure a
SNAP but not (3 or y SNAP activities. Secl7p has been shown to be functionally
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equivalent to a SNAP and to interact with Secl8p in binding Golgi membranes in a
similar way to NSF/SNAP interactions (Griff et al., 1991). However to date a y
SNAP homologue has not been identified within yeast cells. Not only are
NSF/SNAP involved as a complex mediating vesicle fusion in the mammalian system
but this mechanism seems to be conserved in evolution between diverse systems.
Obviously such general protein recruitment onto membranes requires a membrane
receptor which has been shown to interact in a saturable manner with the fusogenic
complex.
1.2.5. 20S particle involved in membrane docking/fusion
Coimmunoprecipitation of a recombinant myc tagged NSF (NSFmyc) and a SNAP
was shown to be dependent on the presence of an integral membrane receptor protein .
This NSF/SNAP receptor was shown to complex with NSF and SNAP during
sucrose gradient velocity centrifugation with a sedimentation coefficient characteristic
of a 20S complex. This complex could not assemble in the presence of NEM-treated
NSFmyc and the complex was also shown to disperse upon ATP hydrolysis (Wilson
et al., 1992). The real breakthrough in identifying proteins that interact with both
NSF and SNAP came when an affinity purification technique was employed to isolate
potential SNAP receptors from the 20S complex within bovine brain cytosol
exploiting the stability of the complex in the presence of either Mg-ATPyS or of ATP
without magnesium present (Sollner et al., 1993a). NSFmyc, SNAP, ATPyS and a
detergent- solubilised membrane preparation derived from bovine brain were
incubated and complex isolation was achieved using an anti-myc epitope antibody
bound to a solid support. The complex was disassembled in the presence of ATP-
Mg"1"1" and three new proteins were visualised in the eluate along with NSF and SNAP.
Each protein was identified by creating tryptic peptides which were then sequenced
and found to be derived from proteins that had previously been identified as abundant
synaptic proteins: two isoforms of syntaxin (A and B) (Bennet et al., 1992);
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synaptobrevin (or VAMP 2) (Baumert et al., 1989; Elferink et al., 1988); and a
synaptosomal-associated protein of 25kDa (SNAP 25). Synaptobrevin is an 18kDa
protein anchored to the cytoplasmic surface of synaptic vesicles by a carboxy-terminal
transmembrane domain whereas syntaxin is a 35kDa protein with a carboxy terminal
membrane anchor associated with the presynaptic membrane.
Neurotransmitter release is blocked by a group of structurally related toxin proteins
produced by Clostridium botulinum. Tetanus toxin and botulinum toxins (A-G) have
been shown to be zinc proteases but their mechanism of action seen by the ultimate
inhibition of neurotransmitter release has only recently been identified. Using highly
purified synaptic vesicles from rat brain it was shown that both tetanus toxin and
botulinum toxin B (BoNT/B) selectively cleaves VAMP/synaptobrevin (Schiavo etal.,
1993). In another study using intact nerve terminals (synaptosomes) it was shown
that BoNT/A selectively cleaves SNAP 25 (Blasi et al., 1993). It also seems likely
that BoNT/C will be shown to cleave syntaxin, the third component of the putative
docking/fusion complex (Huttner, 1993).
Since each toxin is capable of blocking neurotransmitter release this gives direct
evidence that synaptobrevin, SNAP 25 and syntaxin are components of a prefusion or
fusion complex in neurons. Since NSF/SNAP seem to be involved as a general
fusogenic complex these membrane proteins could associate and mediate a synaptic
vesicle fusion event. The specificity of such fusions may be mediated by the
interaction of the vesicle SNAP receptor (v-SNARE), synaptobrevin and the target
SNAP receptor (t-SNARE), syntaxin in the presynaptic membrane. Within the 20S
complex the NSF/SNAP particle may act as a proof-reading mechanism for the
interaction between the v- and t-SNAREs to elicit correct vesicle fusion events. The
third SNAP receptor isolated, SNAP 25, is a soluble protein which associates with
membranes by the addition of palmitoyl moieties to cysteine residues within its
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sequence (Oyler et al., 1989). Given the requirement for fatty acyl CoA in vesicular
transport systems (Glick and Rothman, 1987) in vitro SNAP 25 could in fact aid the
membrane association/assembly of the 20S complex and facilitate membrane fusion.
Fusion between cellular membranes can occur constitutively, as seen when transport
vesicles from the ER fuse with the Golgi or can be closely regulated, as in secretory
storage vesicles fuse with the surface membrane upon receipt of a signal (e.g GTP or
calcium). The calcium-regulated protein synaptotagmin (p65) coimmunoprecipitates
with syntaxin (Bennet et al., 1992) but it was not affinity purified from bovine brain
cytosol in the 20S complex using NSFmyc and so was not thought to be involved in
vesicle docking/fusion events. However, recent studies looking at the components
within the 20S complex in vitro have given some evidence as to the involvement of
synaptotagmin in the 20S complex and to the mechanisms involved in protein complex
association and dissociation during vesicle docking and fusion events (Sollner et al.,
1993b). The three SNAREs (synaptobrevin, syntaxin, and SNAP 25) can form a
stable complex in the absence of NSF and a SNAP, thus promoting the idea that the
specificity seen during vesicle docking events is through v-SNARE/t-SNARE
recognition. Immunolocalization of SNAP 25 and syntaxin to the plasma membrane
in PC12 cells seems to suggest that in the case of the synapse the active t-SNARE
component may have two subunits.
Synaptotagmin was shown to bind this SNARE complex in the absence of NSF and a
SNAP but could be displaced by the addition of pure a SNAP. This may account for
the previous absence of synaptotagmin within isolated 20S complex and suggests a
common site of binding between a SNAP and synaptotagmin on the SNARE
complex. Based on these in vitro studies it has been suggested that synaptotagmin
acts as a 'fusion clamp' to prevent constitutive fusion from occurring in the absence of
a signal for exocytosis (Bennett and Scheller, 1993). Once this signal is received the
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synaptotagmin can be displaced by a SNAP binding to the SNARE complex which
promotes NSF binding and ultimately leading to bilayer fusion. Upon fusion ATP
hydrolysis may cause the release of NSF/SNAP so disrupting the SNARE complex.
This specific coupling of membranes and the assembly of fusion complex may be
additionally regulated by the interaction of Rab proteins (small GTP binding proteins).
1.2.6 Vesicle SNAP receptors (v-SNAREs) in yeast
The biochemical isolation of these fusion components which act at the synaptic cleft
during neurotransmitter release has allowed the identification of a number of
homologous proteins in other diverse biological systems. v-SNAREs and t-SNAREs
have been previously characterised by genetical analysis within yeast, and have been
shown to block/affect secretion at a number of stages (see Table 1).
Mutational analysis in S. cerevisiae originally identified nine sec mutants and two bet
mutants that participated in ER to Golgi transport (Novick et al., 1981; Newman and
Ferro-Novick, 1987). The SEC22 gene encodes a small integral membrane protein
showing homology to mammalian synaptobrevin. The sec22 mutant allele has been
shown to cause a block in secretion at an early stage of the secretory pathway between
the ER and Golgi leading to the accumulation of 50 nm vesicles which can be
visualised under the EM at the nonpermissive temperature. Genetic analysis of sec
mutants acting between the ER and Golgi has implicated the SEC22 gene product in
vesicle fusion events at the same stage as the SEC18 and SEC17 gene products.
The ras-related small GTP binding protein Yptlp has been proposed to participate in
ER to Golgi membrane fusion acting in the regulation through the binding and
hydrolysis of GTP (Segev et al., 1988). Multi-copy suppressors of ypt 1 mutant cells
SLY12 (identical to BET1) and SLY2 (identical to SEC22) were identified and their
gene products were shown to interact with Yptlp (Dascher et al., 1991; Ossig et al.,
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1991; Newman et al., 1992). The primary structures of Sly2p(Sec22p) and
Slyl2p(Betlp) resemble that of Vamplp and synaptobrevin, with the highest region of
conservation between the sequences of these proteins being in a short region
preceding the membrane spanning domain. BOS1, a gene that was originally
identified as a multi-copy suppressor of a betl mutation encodes an integral membrane
protein required for ER to Golgi transport. Transport-competent vesicle intermediates
were isolated from an in vitro system reconstituting ER to Golgi transport in
permeabilised yeast cells using an antibody against Boslp.
Table 1 Synaptobrevin, syntaxin and rab proteins in the yeast
Saccharomyces cerevisiae







Betl/Slyl2 ER to Golgi
Sec22/Sly2 ER to Golgi
Sncl/Snc2 Golgi to PM




S so 1 /S so2 Golgi to PM
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These vesicles were shown to contain Boslp/Sec22p/and Yptlp but not Betlp. This
shows both a genetical and biochemical interaction of a v-SNARE (Sly2p/Sec22p) in
fusion competent transport intermediates with a small GTP binding protein (Yptlp).
Betlp is thought to be associated with a denser group of ER membrane vesicles (Lian
and Ferro-Novick, 1993).
The two SNC genes of S. cerevisiae encode protein homologues of synaptobrevin.
Haploid mutants of either of these genes show no apparent phenotype but sncl/snc2
mutants show conditional lethality and accumulate post Golgi transport vesicles
similar to those observed at the nonpermissive temperature in a sec6 mutant in yeast
(Protopopov etal., 1993).
1.2.7 Target vesicle SNAP receptors (t-SNAREs) in yeast
Three genes have been identified in S. cerevisiae that encode proteins with a carboxy-
terminal membrane anchor and display significant homology to syntaxin primarily
over a 70 amino acid segment near the membrane anchor region. The first of these
proteins is encoded by the SED5 gene. The SED5 gene was identified as a multi-copy
suppressor of the erd2 mutation and encodes a 39kDa integral membrane protein
which has been localised using immunofluorescence to punctate structures throughout
the cell (Hardwick et al., 1992; Hardwick and Pelham, 1992). Another syntaxin-like
protein has been identified at a later stage of the secretory pathway encoded by the
PEP12 gene and is involved in the targeting of proteins from the late Golgi
compartment to the vacuole (Becherer and Jones, 1992). The two yeast genes SSOl
and SS02 have recently been identified by their ability to suppress in high copy the
late acting secl-1 secretory mutant and show the closest homology to the mammalian
syntaxins (Aalto et al., 1993). A number of other late-acting sec mutants are also
suppressed by SSOl and SS02 genes (sec 3, 5, 9 and 15) suggesting the interaction
of these syntaxin-like proteins within a membrane associated protein complex. That
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this complex interaction is involved in vesicle membrane docking and fusion events is
suggested by the accumulation of 100 nm vesicles in the absence of both Ssolp and
Sso2p which is characteristic of the phenotype observed for the late-acting sec mutants
seen at the restrictive temperature. Each stage of vesicle-mediated protein transport
seems to have a specific t-SNARE present which may mediate the docking/fusion of
specific vesicles to the appropriate target membrane.
What has emerged from both a biochemical and genetical analysis of vesicle
membrane fusion events is that there is an assembly of a large multimeric protein
complex between two membrane bilayers that facilitates their fusion. Why do two
opposing bilayers require such a complex for fusion to happen ? The physical
environment surrounding membranes in vivo must be taken into consideration. In
their natural state membrane bilayers are surrounded by a shell of water molecules
bound to the polar head groups that set up a net repulsive force between closely
opposed bilayers stopping spontaneous fusion. It seems counterintuitive that a large
and bulky protein complex which itself is probably hydrated could facilitate such
fusion events. It seems likely that this large complex may have a number of
important roles (a) bringing two specific membranes close enough for fusion to occur
(b) intricate conformational changes within the protein complex can expose internally
orientated hydrophobic residues that may allow local bilayer protrusions to fuse and
(c) regulating the number and time allowed for these fusions to occur.
1.3 Regulation of intracellular membrane traffic
1.3.1 GTP binding proteins
A large number of GTP binding proteins have been identified in higher and lower
eukaryotes and have been classified into two broad families: the ras -like small
monomelic GTP binding proteins (20-30 kDa) and the heterotrimeric G proteins
(Gapy)- GTP binding proteins are involved both in the response of cells to an
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external stimulus which is transduced across the plasma membrane (heterotrimeric G
proteins) and in mediating vectorial transport processes such as protein synthesis. By
alternating between two different conformations in a nucleotide-dependent manner
GTP binding proteins act as molecular switches. GTP binding proteins are active in
the GTP bound form and inactive on hydrolysis (not dissociation) of GTP to GDP.
This switch can be used to introduce vectoriality into a cellular process, as seen for
protein synthesis, via the regulation of GTP-GDP exchange and GTP hydrolysis. Do
small GTP binding proteins have a role in such intracellular trafficking processes?
Three lines of evidence support the involvement of small GTP binding proteins in
vesicular transport. Firstly, mutations in each of the four yeast genes encoding small
GTP binding proteins (ARF1, SARI, YPT1 and SEC4 ) result in defects at various
stages of the secretory pathway. The use of in vitro transport assays has further
subdivided these small GTP binding proteins into two distinct groups; the Sec4/Yptl
family of proteins which seem to be involved in regulating the docking/fusion of
intermediate transport vesicles at the plasma membrane and between the ER and Golgi
apparatus respectively, and a subfamily of proteins that are the products of the SARI
and ARF1 genes that appear to be involved in vesicle formation from the ER and
vesicle coat formation in the Golgi apparatus respectively. Secondly, the mammalian
Rab proteins share 25-60% homology to the Sec4/Yptl family of proteins. Over 30
individual Rab proteins have been identified so far, and have been localized to distinct
intracellular compartments. A combination of both in vivo and in vitro studies has
shown their probable role in the regulation of both exocytotic and endocytotic
transport processes (for review see Zerial and Stenmark, 1993). Finally, the most
compelling evidence for the participation of small GTP-binding proteins in vesicular
transport is that most in vitro transport assay systems are inhibited by the non-
hydrolysable analogue of GTP, GTPyS (although the underlying mechanism may not
be exactly identical due to the varying concentration of GTPyS and cytosol
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requirement needed in each case).
1.3.2 Regulation of vesicle formation events
The small GTP-binding proteins Arflp and Sarlp seem to be implicated in vesicle
formation from the Golgi cisternae in mammalian cells and the ER in yeast cells
respectively. The Sarlp in yeast is a small GTP-binding protein originally identified
as a supressor of the secl2-l mutation and shown to be required for ER to Golgi
transport (Nakano et al., 1989). Sarlp is 35% identical to mammalian ARF. The
SARI gene however cannot suppress a sec12 deletion mutant which indicated a need
for a direct functional interaction of the Sarlp with the integral membrane glycoprotein
Secl2p in vivo. In vitro studies have also shown that vesicle formation requires the
direct interaction of both these proteins (Oka et al., 1991). It was subsequently found
that Secl2p was a GDP/GTP exchange factor (Barlowe and Schekman, 1993). Other
SEC genes have been shown to participate in ER to Golgi transport. The Sec23p was
identified as a GTPase activating protein specific for Sarlp and forms a complex with
Sec24p (Yoshihisa et al., 1993). A basic model is emerging in which Sarlp with
Secl2p binds GTP, assocoiates with the ER and then hydrolyses GTP with the aid of
a Sec23p/Sec24p complex to catalyse the formation of transport vesicles (Figure
1.2).
ARF was originally identified as a cofactor involved in the ADP-ribosylation of the a
subunit of a trimeric Gs protein by cholera toxin (Schleiffer et al., 1982; Kahn and
Gilman, 1984). Mammalian Arfp has been localised to the Golgi apparatus using
specific antibodies and is part of the non-clathrin coat surrounding intermediate Golgi
vesicles (Stearns et al., 1990; Serafini etal., 1991). Inhibition of intra-Golgi
transport assays with GTPyS results in the accumulation of non-clathrin coated vesicle
intermediates and several of the coat proteins (COP) have been characterized: a COP,
160kDa; p COP, 1 lOkDa; p' COP, 102kDa; y COP, 98kDa; 5 COP , 61kDa; e COP,
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36kDa and t, COP, 20kDa and the G protein ARF (Stenbeck et al., 1993; Waters etal
1991). Inhibition of transport by NEM however leads to the accumulation of
uncoated vesicles (75 nm) which are membrane associated. Coated vesicles seem to
be precursors of the uncoated vesicles as inhibition with both GTPyS and NEM
results in the formation of coated vesicles. A cytosolic complex termed 'coatomer'
containing the COP subunits of the non-clathrin coated Golgi transport vesicles was
purified from bovine brain cytosol. ARF was not associated with this cytosolic
coatomer complex yet is part of the non-clathrin coated Golgi vesicles.
Could ARF be responsible for coat assembly/disassembly at the Golgi membrane and
thus mediate vesicle formation? The ability of purified pools of recombinant
myristoylated ARF and coatomer to bind to Golgi membranes in the presence of
GTPyS, Brefeldin A (BFA) and AIF4" has been analysed. Binding of the coatomer to
Golgi membranes was dependent on the presence of ARF and enhanced by both
AIF4" and GTPyS but inhibited by BFA (Helms et al., 1993; Donaldson et al., 1991).
In this way coatomer assembly on Golgi membranes is thought to involve firstly the
activation of ARF by the binding of GTP which allows association with a Golgi
membrane receptor in a myristoyl dependent process and activation of coatomer
assembly onto Golgi membranes. The interaction of a nucleotide exchange protein on
the target membrane could result in GTP hydrolysis and so the [GDP] ARF would
then dissociate and disperse coatomer into a cytosolic pool ready for the next round of
vesicle transport. BFA inhibits this pathway by inhibiting the exchange ofGTP for
GDP bound to ARF so that ARF is unable to associate with the Golgi membranes so
deterring coatamer assembly on Golgi membranes and preventing vesicle formation
(Figure 1.2).
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Figure 1.2 Two small GTP-binding protein dependent mechanisms
within yeast that promote vesicle budding




















However, recent data has suggested that there may be a requirement for coatomers
during ER to Golgi transport. The SEC21 gene is required for ER to Golgi transport
in S. cerevisiae and encodes a protein which participates in a cytosolic complex
which has been shown to be the yeast homologue of the mammalian coatomer
(Hosobuchi et al., 1992). Sec21p (a 105 kDa protein) is homologous to y-COP, a
coat subunit of non-clathrin coated vesicles (Stenbeck et al., 1992). The functional
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role of coatomer in ER to Golgi transport is still to be clarified.
1.3.3 Regulation of intermediate vesicle docking/fusion events
It seems that vesicle docking/fusion within eukaryotic cells involves the initial
recognition of a vesicle membrane protein (v-SNARE) to a corresponding target
membrane protein (t-SNARE) and the subsequent recruitment of soluble proteins
(NSF and SNAPs) to facilitate bilayer fusion (as mentioned in Section 1.2.5). One
possible method of regulation of this process could be through small GTP-binding
proteins at various stages of the secretory pathway (for review see Novick and
Brennwald, 1993).
The SEC4 gene product (Salminen and Novick, 1987) was first implicated in
constitutive secretion by the isolation of a sec4-8 temperature sensitive mutant which
blocked secretion late in the pathway accumulating post-Golgi vesicles (80-100 nm) at
the restrictive temperature. Sec4p has been localised to the cytoplasmic face of both
secretory vesicles and the plasma membrane using polyclonal antibodies. Pulse chase
studies however show an initial soluble pool of Sec4p which rapidly becomes
membrane-associated in a saturable manner (Goud et al., 1988) suggesting a cyclical
process in which Sec4p exchanges between a membrane bound and a soluble form. A
genetic interaction has been shown between the SEC4 gene and several other late
acting SEC genes (SEC2, 5, 8, 10 and 75) and a physical interaction has been shown
with Sec8p and Secl5p within a 19.5S particle (Bowser et al., 1992). It seems that
the small GTP-binding protein, Sec4p, interacts in some late-acting protein complex
possibly involved in the regulation of docking/fusion of secretory vesicles with the
plasma membrane in yeast.
Is there evidence of a synaptobrevin/syntaxin-like interaction involved at this stage in
exocytosis? As mentioned before (see Table 1) Sec4p and Sncp have been
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colocalized to post-Golgi vesicles and Rab3 (Touchot et al., 1987; Matsui et al„ 1988)
and VAMP on synaptic vesicles. In both cases a small GTP-binding protein may
interact either directly or indirectly with a VAMP-like protein on the surface of a
vesicular transport intermediate involved in vesicular docking/fusion events. What of
the target membrane? The secretory mutant protein Seclp was originally identified to
be a late acting protein in the exocytotic process. Genetic interaction has been shown
between SEC1 gene and four other genes (SEC3, 5, 9 and 15), again suggesting a
late-acting protein complex which is involved in exocytosis from the plasma
membrane. Two yeast genes, SS01 and SS02, were recently identified as
suppressors of a secl-1 mutation (see Section 1.2.7) and have homology to
syntaxins.
These studies suggest a model in which a v-SNARE (Snc protein) interacts with a
partner t-SNARE (Ssolp or Sso2p) in an initial recognition event between two
membranes. This then provides a scaffold on which a number of soluble proteins
(Seel, 2, 3, 4, 5, 6, 8, 9, 10 and 15p) may be involved in addition to the previously
identified 'fusogenic proteins' Secl8p (NSF) and Secl7p (aSNAP) to form a protein
complex which facilitates the final bilayer fusion event. This process may be further
regulated by Sec4p in a mechanism common to intracellular fusion events within
membrane trafficking in vivo (see Figure 1.3). Specific functions have not been
identified for proteins involved within this late acting complex and they may represent
effector components that regulate the cycling of Sec4p between a membrane bound
(active) conformation and a soluble (inactive) conformation and in doing so regulate
the actual fusion event itself.
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Figure 1.3 Regulation of vesicle docking/fusion by small OTP
binding proteins.
Proposed model for the regulation of vesicle fusion events by small GTP binding
proteins. This model represents a basic concept of this fusion process in a
constituitive secretory system which may be regulated further by a number of GTP
activating and inhibitory proteins. Regulated secretion (such as seen at the synaptic
cleft) may also be under the control of calcium-binding proteins such as
synaptotagmin.
Donor membrane




CD v - SNARE (Snc lp)
t - SNARE (Ssolp, Sso2p)
IxgdpI GTP binding protein1
(Sec4p)
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^ - - ' 15p and Secl7,18p)
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This type of interaction can also be postulated between the ER and Golgi apparatus at
which stage the small GTP binding protein Yptlp acts, possibly in conjunction with
the syntaxin-like protein Sed5p (Hardwick and Pelham, 1992), and between the late
Golgi compartment and the vacuole where the syntaxin-like protein Pepl2p (Becherer
and Jones, 1992) has been identified. That a similar mechanism could regulate these
events is suggested by the identification of Seclp-related proteins Slylp and Siplp
(Aalto et al., 1992) which function in intracellular transport between the ER and Golgi
apparatus (Dascher et al., 1991) and from the Golgi to the vacuole (Wada et al., 1990)
respectively. The first hint of a related mechanism within mammalian cells has been
given with the identification of a Secl-related protein, Muncl8p (Hata et al., 1993).
Once fusion has occurred both v- and t-SNAREs are on the same membrane and must
be recycled to their appropriate compartments. SNAREs may also be found in an
inappropriate membrane during their initial biosynthesis as they are directed to their
final point of action within the cell. It may be that small GTP-binding proteins act as a
molecular proof-reading mechanism which only favours correct vesicle interactions
through correct SNARE interactions.
Yet basic biochemical evidence still has to be found concerning the details of exactly
which v/t-SNAREs recognise and physically interact together, how this interaction is
affected by NSF and SNAP and how the small GTP-binding proteins regulate this
interaction. What of the stages leading up to membrane fusion that had previously
been identified as prefusion complexes that underwent a maturation process before
fusion actually occurred (Wattenberg et al., 1986)? Some of these questions are now
beginning to be addressed for proteins involved at the synaptic cleft during
neurotransmitter release (Sollner et al., 1993b) using in vitro reconstitution assays.
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1.4 Outline of project
The initial aim ofmy project was to identify proteins which interacted with the Secl8p
from S. cerevisiae. The Secl8p had been identified as a homologue of the mammalian
protein NSF and so was implicated in membrane fusion events. A genetic interaction
had been shown between the SEC18 gene and the SEC17 gene (a SNAP homologue)
although no other soluble/membrane proteins had been identified. Two approaches
were taken: first, affinity purification of interacting proteins using a recombinant
Secl8p fusion protein encoded by a chimaeric gene consisting of the complete ORF of
the SEC18 gene and a DNA fragment encoding three IgG binding domains of
Staphylococcus aureus Protein A moiety. A genetic approach was also used to
produce dominant negative mutants of the SEC18 gene to screen for novel genes that
interact with the SEC18 gene. This latter approach proved to be more successful in






2.1 Chemicals / antibodies / enzymes
Most materials were obtained from BDH Chemicals, Sigma Chemical Co., or Fisons
Ltd. [a-35S]-dATP (>600 Ci/mmol) was obtained from Amersham International pic.
Fast Flow IgG Sepharose was obtained from Pharmacia and Poly-Prep columns from
Bio-Rad. The CPY antibody was kindly supplied by Dr. N Bryant and the Secl8p
and Secl7p antibodies were raised as described in Appendix to Chapter 3.
2.2 Bacterial / yeast strains and plasmids
Strains of E. coli and S. cerevisiae used in this study are described in Table A.l
and A.2 of the Appendix. Plasmids used within this study are also presented in the
Appendix inTable A.3 and A.4 with a description of their origin.
2.3 Bacterial plates / media
In general all bacterial cultures were grown in Luria Broth (L-Broth) consisting of 1%
(w/v) tryptone, 0.5% (w/v) yeast extract, 0.5% (w/v) NaCl supplemented with the
appropriate antibiotic (ampicillin or kanamycin) to a final concentration of 15 pg where
necessary. For blue/white colony selection the medium also contained 15 pM IPTG
and 0.005% X-gal. Addition of 2% (w/v) agar to this medium gave plates.
In order to maintain its F' plasmid,the bacterial strain NM522 was stored on M9
minimal plates which were made as follows : 2% (w/v) agar and 0.4% (w/v) glucose
were autoclaved and left to cool slightly. 100 X additive (0.1 M magnesium sulphate,
0.01 M calcium chloride) and 10 X M9 salts (7% (w/v) sodium phosphate (dibasic),
3% (w/v) potassium phosphate (monobasic), 0.5% (w/v) NaCl, 1% (w/v) ammonium
chloride) were added to a final concentration of 1 X and this was supplemented with
0.0002% vitamin B^
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2.4 Yeast plates / media
Yeast cultures were generally grown in YEPD medium (rich medium) containing 1%
(w/v) yeast extract, 2% (w/v) bacto peptone, 2% glucose. Selective medium was also
used containing 0.7% (w/v) yeast nitrogen base (without amino acids), either 2-3%
(w/v) glucose (SD), 2-3% (w/v) galactose (SG) or 2-3% (v/v) glycerol/ethanol as a
carbon source and the appropriate amino acids at a final concentration of; 20 |ig/ml
histidine, 30 (tg/ml leucine, 20 (ig/ml uracil, 20 (lg/ml tryptophan. The addition of
1% (w/v) casamino acids (supplemented wih uracil), which are produced
commercially by the acid-hydrolysis of casein (a milk protein), was also used as it
contains most of the common amino acids and is rich in the essential ones. Again
addition of 2% (w/v) agar gave plates.
Yeast sporulation plates were used and basically contained a high carbohydrate and
low nitrate medium consisting of 1% (w/v) potassium acetate, 0.1% (w/v) yeast
extract, 0.05% (w/v) glucose, 2% (w/v) agar.
Methods
2.5 DNA manipulations
All general DNA techniques such as restriction endonuclease digestion, extraction with
phenol/chloroform, precipitation in ethanol and ligations were performed as described
by Sambrook etal. (1989).
Gel electrophoresis, for the separation and visualization of DNA fragments was
carried out using agarose gels between 0.4% and 1% (w/v) agarose; DNA fragment
size was estimated by comparing their mobility through an agarose gel with those of
fragments of known size liberated by digestion of phage X DNA with Bst EII or
present in a commercially available 1 kbp DNA ladder.
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2.6 Transformation of bacterial and yeast cells
DNA was transformed into bacterial cells which had been treated with CaCl2 as
described by Sambrook et al. (1989). Transformation of LiOAc treated yeast cells,
using single stranded carrier DNA was performed as described by Geitz et al. (1992).
2.7 Stock preservation
All bacterial and yeast cultures were preserved in 15% (v/v) glycerol and stored at
-70°C.
2.8 Random Mutagenesis
(a) Mutagenic polymerase chain reaction (PCR)
Mutagenic PCR was performed essentially as described by Muhlrad et al. (1992).
The PCR reaction contained the following components: lOng DNA template ; IX
reaction buffer (10 X stock : 1 M Tris.HCl pH8.0; 5 M KC1; 1% (v/v) Triton X100);
1 mM each dGTP, dCTP and dTTP; 200 pM dATP; 2.5 units of Taq DNA polymerase
(Promega). The reaction was first optimised for MgCl2 concentration (from 1.5 mM
to 6 mM) measured by the appearance of a PCR product. An appropriate MnCl2
concentration was then added. Reactions were carried out in a final volume of 100 pi
and overlaid with 50 pi mineral oil.
(b) Propagation in the mutD bacterial strain.
The E. coli mutD bacterial strain has a deficient DNA proof-reading ability (Echols et
al., 1983) and is resistant to the antibiotic rifampycin. The plasmid to be mutagenised
was transformed into the mutD strain. Transformed cells were incubated for a further
40 min at 37°C in L-Broth during a recovery period then transferred into a 50 ml L-
Broth culture containing the appropriate antibiotic and shaken at 37°C overnight.
Mutagenised DNA was recovered from this culture using standard DNA procedures.
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2.9 Rapid isolation of piasmid and chromosomal DNA from yeast
(Hoffman and Winston, 1987)
This protocol describes the isolation of DNA from the yeast S. cerevisiae which can
be used in the transformation of E. coli for piasmid rescue. This procedure also
releases chromosomal DNA which following a further two ethanol precipitations can
be digested by restriction endonucleases and analysed by Southern blot analysis.
The yeast strain was grown in 5 ml of YEPD medium overnight until the stationary
phase of growth. 1.5 ml of this culture was harvested in a microfuge tube and the
supernatant removed. The cell pellet was resuspended in any residual liquid and 0.2
ml of lysis buffer (2% Triton X100, 1% SDS, 100 mM NaCl, 10 mM Tris.HCl
pH8.0 and 1 mM EDTA) added. A further 0.2 ml phenol / chloroform : isoamyl
alcohol (24 : 1) and 0.3g of glass beads were added to the resuspended yeast pellet.
This suspension was vortexed for 2 min (this step is important as further vortexing
may lead to shearing of chromosomal DNA) then centrifuged for 5 min in a bench top
microfuge at 15,000 rpm. The upper aqueous layer was removed and DNA was
ethanol precipitated from this and resuspended in 50 (0.1 of TE buffer. 10 fil of this
DNA was used to transform 200 (il of competent E. coli cells. For Southern blot
analysis at least 15 (il of this DNA was digested.
2.10 Southern hybridisation
Transfer of DNA from agarose gels to a nylon Hybond H+ filter and subsequent
hybridization of a nonradioactively digoxigenin labelled probe to the filter were carried
out essentially as described by Sambrook et al. (1989) using a method based on that of
Southern (1975). Approximately 3 jag of purified DNA was labelled following the
method described by Boehringer Mannheim Biochemica: DNA synthesis was primed
on denatured DNA by random hexadeoxynucleotides in the presence of the Klenow
fragment of E. coli DNA polymerase I and the nucleotide analogue digoxigenin-11-
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dUTP. Detection of the digoxigenin-labelled probe was with an anti-digoxigenin-
alkaline phosphatase conjugate which was visualized by an enzyme linked colour
reaction.
2.11 DNA sequence analysis
Two methods of sequencing were employed in this work, one based on single-
stranded M13 (as used in Chapter 3) and the other based on double stranded plasmid
DNA (as used in Chapter 4). Single-stranded Ml3 DNA was prepared as described in
Sambrook et al. (1989) and the sequencing reactions were performed as described in
the BRL 'M13 cloning/dideoxy sequencing instruction manual' using a BRL
sequencing kit. Double stranded DNA sequencing reactions were performed as
described in the 'USB Sequenase version 2.0' manual. Both methods employed the
dideoxy chain termination method of Sanger etal. (1977) for sequencing in the
presence of [a35S]-dATP. The sequencing reactions were electrophoresed on 6 - 8%
acrylamide wedged gels containing 8 M urea.
2.12 Expression of Protein A fusion proteins from thePiac promoter.
The E.coli strain NM522 transformed with either a pKpra or a pAXl 1, 12 or 13
derived plasmid was grown in 100ml of selective medium (L-Broth containing the
antibiotic, kanamycin) at 37°C to an O.D600 of 0.6. To induce expression from the
lac Z promoter IPTG was added to a final concentration of 0.25 mM and the cells were
grown for a further 2 - 4 hrs.
2.13 Expression of p-galactosidase fusion proteins from the PR
promoter.
The E.coli strain pop2136 transformed with a pEXl 1, 12 or 13 derived plasmid was
grown in 100 ml of selective medium (L-Broth containing the antibiotic, ampicillin) at
30°C to an O.D600 of 0.5. To induce expression from the PR promoter of
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bacteriophage X the cells were then incubated at 42°C for a further 4-5 hrs.
2.14 Fractionation of bacterial cultures by centrifugation.
The fractionation of induced bacterial strains was similar in all cases. Cells were
harvested by centrifugation at 8,000 rpm for 8 min then the cell pellet was washed
once with 0.1 M Tris.HCl pH7.4 and resuspended in 5 - 10 ml of this buffer.
Lysozyme was added to a final concentration of 1 mg/ml and this suspension was
placed on ice for 20 min. The yeast cells were lysed by sonication (4 X 30sec bursts
with 2 min intervals on ice between each burst). The suspension was then
fractionated; an initial low speed clearing spin of 3,000 rpm for 5 min yielded a pellet
(P3). The resultant supernatant was subjected to a further centrifugation at 20,000
rpm for 20 min to give an insoluble (P20) and a soluble (S20) fraction. Both the P3
and P20 fractions were resuspended in a volume similar to the S20 fraction (5 - 10 ml)
and analysed by SDS PAGE and subsequent Western blot analysis. Using this
method P-galactosidase fusion proteins tended to fractionate in the P3 fraction whereas
protein A fusion proteins fractionated in the S20 fraction.
2.15 Use of Fast Flow IgG Sepharose for the purification of Protein
A fusion proteins.
The basic method used for purification of protein A fusion proteins from either
bacterial or yeast cultures is as follows: 1 ml of IgG Sepharose (wet volume) was
equilibrated, by washing (4 times) with TST buffer (50 mM Tris.HCl pH7.4, 150
mM NaCl, 0.05% Tween-20). The bacterial or yeast extract was then added to this
equilibrated IgG Sepharose and incubated overnight on a rotating wheel at 4°C. This
suspension was then placed in a 'Poly-Prep' chromatography column and the
unbound material was allowed to flow through. The column was washed with TST
buffer until the OD2go °f the wash coming through the column was zero. 5 - 10 ml of
elution buffer (0.5 M acetic acid adjusted to pH3.4 with ammonium acetate) was then
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added and the eluted material collected and dialysed against 5 L of distilled water
overnight at 4°C. Samples were then frozen at -70°C and freeze dried and
resuspended in an appropriate volume of buffer.
2.16 Yeast glass bead homogenate
The yeast strain was grown in selective medium until the desired OD600 was attained
at which point the cells were harvested (5,000 rpm for 5 min). This cell pellet was
washed once with distilled water then resuspended in the same volume of Lysis buffer
(0.1 M Tris.HCl pH7.0, 2 mM EDTA pH7.4, 20 mM PMSF, 20 mM EGTA, 10
|ig/ml each of pepstatin, leupeptin, chymostatin, and antipain). An equal volume of
glass beads was added and this suspension was vortexed for 4 X 2min with 2min
intervals on ice. This suspension was spun out through the glass beads at 3,000 rpm
for 10-15 min to remove broken yeast cell debris and give a crude yeast lysate.
2.17 Fractionation of crude yeast cell homogenate
Where appropriate the crude yeast cell lysate was further fractionated by
centrifugation at 12,000 rpm for 15 min to give a low speed pellet (PI2). The
supernatant was further centrifuged at 50,000 rpm (100,000 x g) for 1 hour in a
Beckman TL100 rotor to yield high speed pellet (P100) and supernatant (S100)
fractions.
2.18 Chemical mutagenesis of yeast cells using EMS
The yeast strain was grown in 10 ml of YEPD medium overnight at 30°C and 2.5 ml
of the culture was harvested. The yeast cell pellet was washed twice in 50 mM
potassium phosphate buffer pH7.0 and resuspended in a final volume of 10 ml. 300
(il of EMS was added to this suspension in a sterile screw top glass bottle and
vortexed as EMS is poorly miscible in water. This suspension was incubated at 30°C
for 30 min at which point the action of EMS was arrested by adding an equal volume
44
of 10% (w/v) of filter-sterilised sodium thiosulphate. The cells were then harvested
and washed twice with sterile distilled water. The yeast cells were then incubated in
YEPD medium for several generations of growth in a recovery period before plating
out onto selective agar plates and growth at 25°C. This treatment generally resulted in
a 50 -90% lethality.
2.19 Construction of yeast strains and random spore analysis
Yeast strains were constructed within this work by mixing two haploid strains and
growing them overnight at 25°C first on YEPD plates. The strains were then replica-
plated onto selective plates and grown at a temperature which only allowed the growth
of diploid colonies. Yeast strains that grew under such conditions were then
sporulated, by growth on sporulation plates (see Section 2.4) at 25°C for up to 7
days. The extent of sporulation was monitored by visualization under a light
microscope. Once sporulation had occurred the ascus wall was removed to allow the
propogation of individual spores.
As many cells as possible were scraped off from a sporulation plate and resuspended
in 200 (il of sterile distilled water. 40 (il of a 5 mg/ml zymolyase solution was added
and this suspension incubated at 30°C for 1 hr. O.lg of glass beads was added along
with 500 jil of sterile distilled water and this was vortexed for 30 seconds. Dilutions
of this spore suspension were then plated out onto YEPD agar plates and incubated at
25°C to allow germination, yielding individual haploid yeast colonies.
2.20 Determination of yeast mating type
Yeast strains of unknown mating type were individually mixed with the two strains
DC14 MATa; hisl and DC17 MATa; hislunder conditions that selected for growth of
prototrophic diploids. Only yeast strains of opposing mating types will form such
diploids.
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2.21 Processing of yeast cells for viewing under the Electron
Microscope using LR white resin.
(a) Fixation of the yeast cells
To avoid any morphological changes of the yeast cells when subjected to
centrifugation the cells were fixed directly in the growing yeast culture. A 1/10
volume of 10X prefixative solution (10% glutraldehyde, 2% methanol free
formaldehyde, 0.4 M potassium phosphate pH7.0) was added to the growing yeast
culture and allowed to sit at room temperature for 5 min. The cells were then pelleted
by centrifugation at 5,000 rpm for 5 min and resuspended in 1/10 volume of ice cold
IX prefixative solution and allowed to complete fixation for 30 min at 4°C. Excess
fixative was removed by three phosphate buffer washes (0.04 M potassium phosphate
pH7.0) leaving the cell suspension in each change of buffer for at least 5 min.
(b) Periodate treatment of fixed yeast cells
The washed cell pellet was resuspended in 1ml of freshly prepared 1% sodium
metaperiodate (aqueous) and incubated at room temperature for 15 min. The samples
became clumpy at this point and were pelleted by centrifugation at 5,000 rpm for 5
min and washed once in phosphate buffer. The cell pellets were resuspended in 50
mM ammonium phosphate to block free aldehyde sites and were incubated at room
temperature for 15 min before being washed twice with distilled water.
(c) Dehydration of yeast cells
Periodate treated cells were resuspended in 1 ml of 50% ethanol and then pelleted by
centrifugation at 5,000 rpm for 5 min after which they were resuspended in 1 ml of
70% ethanol. At this point cells formed firm clumps which could be dispensed into
microfuge tubes containing 70% ethanol and stored as aliquots at -20°C for several
months. However, in this work processing was carried out immediately. The tubes
containing the samples were placed upright on a rotating wheel with their lids open for
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5 min at room temperature. Dehydration was completed by one 5 min incubation in
95% ethanol followed by a further three incubations in 100% ethanol (a previously
unopened bottle).
(d) Infiltration of dehydrated yeast cells with LR white resin
The last 100% ethanol incubation was replaced with a solution of 2 parts ethanol to 1
part LR white resin and the samples were returned to the rotating wheel for 1 hour (in
a fume hood). The solution was replaced with a 1 : 1 ethanol: resin mix and the
samples rotated for another hour. The samples were incubated, uncapped, in a fresh
1 : 1 resin mix overnight on the rotating wheel in the fume hood (this allows the
ethanol to slowly evaporate thus increasing the resin concentration gradually). The
following day the residual resin was replaced with fresh 100% LR white resin and the
samples were rotated for 1 hour. The resin was then replaced and the samples placed
under vacuum (20 psi) for 15 min to be degassed before being placed back on the
rotating wheel for a further hour.
(e) Embedding of yeast cells in solid LR resin
Small clumps of cells were removed from the samples using a tooth pick and placed
into gelatin capsules filled with LR white resin. The sample was allowed to sink to the
bottom of the capsule and ideally was positioned in the centre. The capsules were then
placed under vacuum for 15 min and polymerization of the resin was achieved by
leaving sealed capsules in an incubator at 45°C-50°C for approximately 2 days.
(f) Grid preparation, sectioning and staining
Sections from the LR white resin blocks were cut by the Department of Pathology,
University of Edinburgh and placed onto gold EM grids. The sections were air dried
on the grids for 2 days before staining. The grids were stained in 2% aqueous uranyl
acetate for 1-5 min then in Reynolds lead citrate for 30 seconds.
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2.22 Electrophoretic separation and detection of proteins
Separation of proteins was achieved by electrophoresis through polyacrylamide gels
following the basic procedure of Laemmli (1970). Polyacrylamide gels ranging from
a 7.5 - 12% (w/v) separating gel with a 5% (w/v) stacking gel were normally analysed
using the Hoeffer 'tall mighty small' gel apparatus using the following solutions:
I. Seperating gel buffer
0.75 M Tris.HCl pH8.8, 0.2% (w/v) SDS
II. Stacking gel buffer
0.25 M Tris.HCl pH6.8, 0.2% (w/v) SDS
IIIAcrylamide solution
40% (w/v) acrylamide, 0.67% (w/v) /V,/V' -methylenebisacrylamide
or 44% (w/v) acrylamide, 0.3% (w/v) N,N'-methylenebisacrylamide (Figure 5.5)
IV. Electrophoresis buffer
0.125 M Tris., 0.2 M glycine, 0.1% (w/v) SDS (final pH of solution is 8.3 with
no adjustment)
V. SDS sample buffer
0.0625 M Tris.HCl pH6.8, 20% glycerol, 4% (w/v) SDS, 5% (w/v) (3-
mercaptoethanol
Proteins were visualized after electrophoresis by either Coomassie Blue staining or
Silver staining:
(a) Coomassie Blue staining
Gels were soaked in a solution of 0.25% (w/v) Coomassie Brilliant Blue dissolved in
50% (v/v) methanol, 7% (v/v) acetic acid for approximately 15 min. Gels were
destained in a solution of 10% (v/v) methanol, 7% (v/v) acetic acid.
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(b) Silver staining
Gels were soaked in 50% (v/v) methanol for at least 1 hr. The silver stain was made
fresh as follows: Solution (a) 0.8 g of silver nitrate was dissolved in 4 ml of distilled
water. Solution (b) 21 ml of 0.36% sodium hydroxide was added to 1.4 ml of 14.8 M
ammonia. Solution (a) was added dropwise to solution (b) with constant stirring and
this was made up to a final volume of 100 ml with distilled water. The gel was soaked
in this solution for 15 min with gentle agitation. The gel was subsequently washed for
at least 5 min in distilled water during which time 100 ml of developer was freshly
made (0.005% (v/v) citric acid, 0.019% (v/v) formaldehyde). The gel was developed
by soaking it in developer until bands appeared on the gel (usually within 10 min of
adding the developer). The developing was stopped by washing the gel in distilled
water then placing / storing it in destain solution.
2.23 Semi-dry blotting of proteins
Proteins were transferred to a nitrocellulose filter (Hybond C extra) using a semi-dry
blotting technique employing the following buffers :
Anode buffer 1: 0.3 M Tris., 20% (v/v) methanol, 0.1% SDS: pH10.4
Anode buffer 2: 25 mM Tris., 20% (v/v) methanol, 0.1% SDS: pH10.4
Cathode buffer: 25 mM Tris., 20% (v/v) methanol, 0.1% SDS: 40 mM
6-amino-Ar-hexanoic acid: pH9.4
Six pieces of Whatman 3mm paper and one piece of nitrocellulose membrane were cut
to the same size as the gel to be blotted. Two pieces of Whatman 3mm paper were
soaked in anode buffer 1, one piece in anode buffer 2 and three pieces along with the
gel in cathode buffer. The nitrocellulose membrane was soaked in distilled water.
These were layered as follows onto the semi-dry blotting apparatus: 2 X pieces anode
1, 1 X pieces anode 2, nitrocellulose membrane, polyacrylamide gel then 3 X pieces
cathode. The area of the gel was measured and it was blotted for 1 hour at 0.8mA X
[area of gel] cm2 ■
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2.24 Western blot detection of proteins.
After transfer of proteins onto a nitrocellulose membrane nonspecific sites on the
membrane were blocked by incubating the membrane for 1 hr in blocking buffer (5%
non-fat dried'Marvel' powdered milk, in TBST buffer: 1% Tween-20, 10 mM
Tris.HCl pH7.4, 150 mM NaCl). Primary antibody was then added into this solution
at an appropriate dilution and incubated for a minimum of lhr to an overnight
incubation with gentle agitation. Excess primary antibody was removed by washing
the membrane 2X15 min then 2 X 5min washes in TBST buffer. The membrane was
then incubated in blocking buffer and incubated with the second antibody (usually a
donkey anti-rabbit HRP conjugate) at a dilution of 1 : 5,000 for 20 min. The
membrane was washed as described above before detection by the Enhanced
chemiluminescence (ECL) detection system (Amersham).
2.25 Isolation of antigen and the immunization of rabbits for antibody
production
Female New Zealand white rabbits were immunized with bacterially expressed and
purified protein A fusion proteins. These fusion proteins were expressed and purified
from the bacterial strain NM522 (as described in Sections 2.12 and 2.15). The IgG
Sepharose purified material could either be directly used to immunise a rabbit if the
material was free of contaminating proteins or the protein of interest could be purified
further by electroelution from an SDS polyacrylamide gel as follows: The sample was
loaded onto an appropriate percentage SDS polyacrylamide preparative gel lane which
has a maximum capacity of 1 ml of sample. After the gel was run (25 mA for 5 hrs or
50 V overnight) it was stained in Coomassie Blue stain for a short period. The
appropriate band was excised, after destaining the gel, as a strip of polyacrylamide
which was cut into a number of smaller pieces. These fragments were placed in
dialysis tubing containing 5 ml of electrophoresis buffer and placed in a tank of this
buffer and subjected to 125 V for 5 hrs. The buffer containing the electroeluted
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protein was then removed and dialysed against distilled water overnight at 4°C.
At least 100 qg of purified protein A fusion protein (in a volume of approximately 150
ql) was mixed to form an emulsion with an equal volume of Freunds complete
adjuvant (1 mg Mycobacterium tuberculosis, heat killed and dried, 0.85 ml paraffin oil
and 0.15 ml mannide monooleate perml of adjuvant) and this was then injected
subcutaneously into the rabbit. A second injection was performed six weeks later but
in this and subsequent injections Freund's incomplete adjuvant (0.85 ml paraffin oil
and 0.15 ml mannide monooleate per ml of adjuvant) was used in the emulsion. A 10
- 40 ml bleed was obtained from the rabbit six days after the third injection. The blood
was left overnight at 4°C to clot and the serum was collected by centrifugation at
3,000 rpm for 15 min. The supernatant was filtered through a 0.22 qm Acrodisc and
sodium azide added to a final concentration of 0.1%. The serum was stored at -20°C
until needed further. If the antibody titre was high in a rabbit after its 5 - 6th boost
injection then that animal was sacrificed and the serum was stored at -20°C.
2.26 Affinity purification of polyclonal antibodies
2 ml of Biorad Affi-gel 10 (wet volume) was washed once with 10 ml distilled water
then twice with 10 ml 0.1 M Hepes pH7.4 (each time allowing the gel to settle out on
ice between washes). Typically 500 qg of (3-galactosidase fusion protein resuspended
in 5 ml of 0.1 M Hepes buffer pH7.4 was bound overnight at 4°C on a rotating
wheel. The suspension was transferred to a 'Poly -Prep' Chromatography column
and washed with 0.1 M Hepes buffer pH7.4 until the O.D28o of the wash was zero.
Any uncrosslinked sites on the gel were blocked by incubation of the column in 1 M
ethanolamine on a rotating wheel at 4°C for 1 hr. The ethanolamine was washed from
the column again with 10 ml 0.1 M Hepes buffer pH7.4.
Immune serum (10-20 ml) was then added to this affinity column and it was
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incubated overnight on a rotating wheel at 4°C. Unbound material was collected and
then the column was washed using 0.1 M Hepes pH7.4 until the O.D280 of the wash
was zero. The bound antibodies were then eluted from the column using 5 ml of 0.2
M glycine pH2.8. 1 ml fractions of this eluted material were collected in microfuge
tubes containing 75 - 100 pi of 1 M Tris. HC1 pH8.0 to neutralise the final solutions.
The O.D280 of each fraction was monitored and the peak of protein concentration
(containing the affinity - purified antibodies) was aliquoted out into 100 pi fractions
containing a final concentration of 0.1% sodium azide and stored at -20°C.
2.27 Detection of f-lactamase activity
p-lactamase activity was measured spectrophotometrically by following a colour
change of the substrate at wavelength of 490 nm using the reagent nitrocefin. A stock
solution of nitrocefin was prepared containing 5 mg nitrocefin dissolved in 0.5 ml of
DMSO and this was made up to a final volume of 10 ml by the addition of 9.5 ml of
0.1 M sodium phosphate buffer (pH7.0) and was stored at 4°C. P-lactamase activity
was measured by adding 50 pi of sample to 0.95 ml of 0.1 M sodium phosphate
solution pH7.0 and 50 pi of nitrocefin stock solution and following the change in
absorbance read at 490 nm.
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Chapter 3
Production of a Secl8-Protein A protein




Over the years a number of proteins have been identified that may be involved in
specific targeting and fusion events occurring during intracellular membrane traffic.
The A-ethylmaleimide-sensitive fusion protein (NSF) was first implicated in
membrane fusion by its ability to restore intercisternal Golgi transport in a mammalian
cell-free assay system (Block et al., 1988, Malhotra et al., 1988). NSF requires
additional soluble NSF attachment proteins (SNAPs) and membrane bound receptors
to attach to Golgi membranes forming a multisubunit complex with a sedimentation
coefficient of 20S. Recent data identified components of this 20S particle from bovine
brain, involved in synaptic vesicle release, using a functionally active recombinant
form of NSF which was C-terminally tagged with the c-myc peptide and purified from
E. coli (Sollner et al., 1993).
A biochemical approach to the isolation of proteins that interact with the yeast
homologue of NSF encoded by the SEC18 gene was attempted. In the absence of a
suitable antibody against Secl8p for good immunoprecipitation analysis a Protein A
tag was attached to the carboxy-terminus of Secl8p. Protein A is a 42 kDa
polypeptide that is a normal constituent of the cell wall of S. aureus and is known to
bind to the Fc domain of antibody molecules. It is essential for this type of approach
that the tagged protein is still biologically active and the tag is not so large as to cause
steric hindrance to complex formation and normal functioning of the protein in vivo.
This chapter presents the steps taken in constructing a hybrid gene encoding a
Secl8pra fusion protein in a yeast expression system. The functional activity of the
hybrid protein was tested relative to the wild-type activity and I attempted to affinity
purify proteins that complex to Secl8p in vivo using various conditions of isolation.
3.2 Construction of a C-terminal tagged version of Secl8 protein
A series of vectors (Geitz et al., 1988) allowing fixed copy levels within yeast are
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commonly used in our laboratory. YEp (yeast episomal plasmid) based vectors
contain the 2|im circle allowing them to have stable, high copy propagation. YCp
(yeast centromeric plasmid) based vectors carry a chromosomal centromere allowing
the plasmid to engage the spindle apparatus of the cell and so give 1-2 copies per cell,
and much greater stability than YEp plasmids. The plasmids YEpGAL and YCpGAL
(see Table A.3 and A.4) both containing the TRP1 gene as a selectable yeast
marker, were used throughout to give two levels of expression of proteins within
yeast when grown on galactose inducing medium, the GAL1 promoter being
repressed in the presence of glucose in the medium (St. John and Davis, 1981; Schultz
et al., 1987).
To create a gene fusion between the SEC18 gene and Protein A - encoding DNA a
new restriction site was required at the 3' end of the SEC18 gene to facilitate the
cloning strategy and produce an in-frame fusion protein. The complete open reading
frame (ORF) of the SEC18 gene including 70 nucleotides of upstream sequence was
cloned into a phage vector to allow the introduction of an Fspl site by the Kunkel
method for site directed mutagenesis as described in Figure 3.1. This fragment
should contain enough information for the expression of the SEC18 gene as sequences
upstream from the transcription initiation site do not seem to be implicated in gene
expression and the promoter elements are thought to function from within the SEC18
gene itself (Eakle et al., 1988).
The plasmid pKpra was used as a source of Protein A-encoding DNA. This plasmid
encodes a Pra - lac Z fusion protein of 26 kDa that contains an N-terminal portion of
Protein A consisting of two and a half IgG binding domains of approximately 16.9
kDa. This portion of Protein A was used both to produce a C-terminal Secl8pra
in-frame fusion and to construct a Pra control to use in future affinity purification
analysis. Firstly, two stop codons (TAA,TAA) and a new Xhol restriction site were
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introduced at the 3' end of the Protein A fragment to ensure the correct translational
termination of the Secl8pra peptide and to facilitate the cloning strategy respectively
producing the construct pKpra2 (Table A.4). This modified Pra fragment was
subcloned into the phage construct Ml3SEC18(FspT) at the 3' end of the SEC18 gene
producing an in frame fusion product which was subsequently subcloned into the
yeast vectors YCplac22, YEplacl 12, YCpGAL and YEpGAL (see Table A.3). The
resulting plasmids pCHl and pCH2 contain a SEClSpra. fusion gene under the control
of the SEC18 promoter whereas pCH3 and pCH4 contain the same gene under the
control of the strong GAL1 promoter. The SEC18 gene has been shown to produce
two gene products of approximately 82 kDa and 84 kDa (Eakle et al., 1988), therefore
it was expected that each construct would encode two gene products of predicted sizes
of approximately 99 kDa and 101 kDa.
AHindlU/Xhol cassette containing a portion of the Pra gene (used for the Secl8pra
fusion construct) was cloned into YCpGAL and YEpGAL. Two oligonucleotides
were used which facilitated the cloning strategy and also allowed the in frame fusion
of the Pra fragment into the plasmids such that it was under the control of the GAL1
promoter (as shown below) and produced the two constructs pCH5 and pCH6
respectively which encode a product of 16.9 kDa (see Table A.4).
Ser
GAL GATCAAAATGTCTCCAAGCT Protein A
TTTTACAGAGGTTCGA
This allowed the study of the effects that expressing just the Pra tag within yeast cells
had in the subsequent affinity purification analysis so distinguishing between non¬
specific and specific binding of proteins to the Secl8p portion of the hybrid.
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3.3 Detection of active fusion protein in vivo
An essential prerequisite for any tagged version of a protein is that the 'tag' does not
interfere with the activity of the protein in vivo. The yeast strain CHY01(see Table
A . 2) has a temperature sensitive mutant seel8-1 allele and cannot grow at the
nonpermissive temperature of 37°C. The Secl8pra fusion protein should be able to
complement this defect when expressed in the yeast strain CHY01 at 37°C if it
functions in vivo.
CHY01 was transformed with plasmids pCHl, 2, 3, and 4 to give the strains
CHY01(pCHl to 4). Growth of these strains was monitored on both glucose (SD)
and galactose (SG) selective media at the permissive (25°C) and restrictive (37°C)
temperatures and compared with that of an untransformed strain (Table 3.1). Yeast
strains CHYOl(pCHl) and CHY01(pCH2) show growth at the restrictive temperature
on glucose selective medium and slight growth on galactose. This suggests that the
internal promoter element within the SEC18 gene can produce enough fusion
transcript to encode Secl8pra fusion protein which is active in vivo thus
complementing the secl8-l mutation. Yeast strains CHY01(pCH3) and
CHY01(pCH4) complement the seel8-1 mutation on galactose medium at 37°C and
slightly on glucose medium at 37°C suggesting again that there is slight leakiness in
the control of the expression of the Secl8pra fusion protein due to the effect of the
internal promoter in the SEC18 gene itself. Complementation of the secl8-l mutation
by both high and low copy number yeast vectors suggests that it is not an abundant
degradation product lacking the protein A moiety that is acting in vivo but the full
length fusion protein.
3.4 Fractionation studies showing the intracellular distribution of
fusion protein
Since the fusion protein complements the sec!8-l mutation it would suggest that it
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was active in vivo and so should have a similar intracellular distribution to that of the
wild-type protein. Yeast cells expressing the fusion construct were lysed using glass
beads and fractionated in the presence or absence of ATP by differential centrifugation
closely following the fractionation procedure used in the characterization of Secl8p
(Eakle et al., 1988). Each fraction was analysed under denaturing conditions using
SDS PAGE and the distribution of the hybrid protein between the various fractions
was monitored by Western blot analysis (Figure 3.2(a) and (b)). The Secl8pra
protein was found to fractionate in a similar manner in the presence or absence of ATP
within the medium. Significant amounts of protein were detected in the PI2 fraction
which has been shown to contain significant amounts of ER / Golgi complex. Also
the hybrid protein fractionates evenly between the high speed membrane pellet (PI00)
containing transient transport vesicles and the supernatant (SI00) fraction.
Unmodified Secl8p has been reported to fractionate mainly between the P100 and
S100 fractions with little association seen with the P12 fraction (Eakle et al., 1988).
Therefore the presence of the fusion protein in the P12 fraction seen in this study
could either be an artifact caused by the overexpression of this fusion protein which
may associate with other intracellular membranes or the Pra tag may be causing the
aggregation of the fusion protein. Elowever, the fact that there is fusion protein in the
PI00 / SI00 fractions supports the conclusion that a proportion of the hybrid protein
is showing a'wild-type' intracellular distribution.
Two forms of the fusion protein were resolved using 7.5% SDS PAGE and were
found in significant amounts in both the 100,000xg pellet (PI00) and supernatant
(S100) fractions as reported for the wild-type protein (Figure 3.2 (c)). Treatment
of the yeast extracts with 0.1M sodium bicarbonate pH12.5 prior to fractionation
removed the fusion protein from the P100 into the S100 fraction (Figure 3.3). This
suggests that the fusion protein is a peripherally membrane associated protein. This
movement is seen also when extracts are treated with 2.5M urea, suggesting that the
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fusion protein is associated with the membrane possibly as a peripheral protein
complex / aggregation. The fractionation studies along with the previous
complementation analysis suggests that a proportion of the hybrid protein when
expressed in yeast is functionally active in vivo and can therefore be used to affinity
purify proteins that act in a 'fusogenic complex' with Secl8p in vivo.
3.5 Initial affinity purification studies of the fusion protein using IgG
Sepharose
The Secl8pra fusion protein seems to be active in vivo and so should interact with the
wild-type Secl8p in functional tetramers that can participate in membrane fusion
events within the 20S fusogenic complex. Purification of this complex was attempted
using the affinity of the Pra tag for the Fc portion of IgG on a Fast Flow IgG
Sepharose column in a single step purification. The basic procedure used to affinity
purify proteins that complex with Secl8p is as described in Materials and Methods. A
number of variations on this basic experiment were tried in the attempt to identify
specific proteins that complexed with Secl8p in vivo. All binding studies were carried
out using lysates prepared from the transformed yeast strain JRY188(pCH3) and the
control strain JRY188(pCH5). Initially the Secl8pra fusion protein was bound from a
PI00 fraction produced from these strains since the 20S complex is membrane
asssociated and a possible membrane receptor could therefore be identified in this way.
Various purifications were done from detergent - solubilised P100 samples (prepared
with either 0.1% Triton X100 or RIPA buffer: 150 mM NaCl, 1% Nonidet 40, 0.5%
DOC, 0.1% SDS and 50 mM Tris.FlClpH8.0). However detection of proteins bound
to the hybrid protein was very difficult even on silver stained SDS polyacrylamide
gels. Possibly any complexes formed in vivo may be transient and dissociate during
the affinity purification procedure so making protein detection difficult.
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(a) a thiol-reversible crosslinker 3,3'-Dithio-bis (propionic acid Nhydroxysuccinimide
ester) (DSP) which has previously been used to isolate membrane bound multi-subunit
complexes (Deshaies et al., 1991). To optimise the degree of crosslinking within
Secl8pra containing yeast extracts, SI00 and PI00 fractions were incubated with 0-12
mM DSP for 30 min at on ice. 0.1 M ammonium acetate was added and the extracts
incubated for a further 10 min on ice to terminate the crosslinking reaction. The
samples were then analysed by SDS PAGE for the disappearance of low molecular
weight proteins and the appearance of large complexed bands on coomassie staining of
the gels. The appropriate amount of crosslinker (0.5-1 mM) was thus added to either
S100 fractions or detergent-solubilized P100 fractions to try and stabilise any
complexes involving Secl8pra prior to binding to IgG Sepharose; (b) an ATP
regenerating system was also added to the initial yeast extract prepared as the
hydrolysis of ATP is thought to destabilise the 20S complex (Wilson et al., 1992) and
(c) the time taken to bind the material to the IgG Sepharose was reduced to
approximately lhr at 4°C to minimise complex disassembly. Unfortunately no
specifically - bound proteins were identified by these procedures possibly due to the
extremely poor recovery of protein from the P100 extracts even using initial large
culture volumes (1L). It may be that the P100 material is lacking a stabilising
'cytosolic factor' for complex assembly and so it was decided to try to purify
complexes from an S12 yeast extract (which contains both the P100 and SI00
fractions). Again, various experiments were designed to purify complexes from the
S12 extract of yeast strains expressing either Secl8pra or the control protein Pra. Two
main procedures that were employed are presented below:
Procedure I: An S12 extract was prepared from yeast strains JRY188(pCH3) and
JRY188(pCH5) and an IgG binding performed in the presence or absence of an ATP
regenerating system (Figure 3.4). ATP is required for the stability of the soluble
form of NSF as shown in a mammalian cell free transport systems. S12 extracts were
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incubated at 4°C with IgG Sepharose on a rotating wheel in an attempt to bind
complexes that have formed with the Secl8pra fusion protein. Non-specifically
bound proteins were removed in an initial wash whereas proteins bound to Secl8pra
or the Pra control were eluted from the IgG Sepharose column using a low pH elution
buffer (which co-elutes the fusion protein and tag protein) and analysed by SDS
PAGE (Figure 3.4(a)). The fusion protein and Pra control along with any
degradation products were identified by Western blot analysis (Figure 3.4(b)).
Comparison of Lanes 1 and 3 in Figure 3.4(a) shows that there are many proteins
that are eluted by a low pH along with the Secl8pra protein and these proteins are also
eluted with the Pra control protein and so represent non-specific binding. Comparison
of Lanes 2 and 4 show that this non-specific binding is not affected by the presence of
an ATP regenerating system. Figure 3.4(b) represents a Western blot analysis of
these samples. Lanes 1 and 2 show that there is only minor degradation of the
Secl8pra fusion protein during the binding procedure and more fusion protein is
recovered in the presence of an ATP regenerating system. Although preliminary
analysis has shown in this work that ATP does not affect the intracellular distribution
of the fusion protein (see Section 3.4) the effects of an ATP regeneration system
may stabilise the fusion protein in a conformation which is more ammenable to
binding and therefore show an altered intracellular distribution. Lanes 3 and 4 show
that the Pra is fully denatured on SDS PAGE and only one low molecular species is
observed. This seems to suggest again that the large amounts of proteins isolated
along with the Secl8pra fusion and the Pra control are not degradation products of the
fusion protein (lanes 1 and 2(b)) or aggregated Pra complexes (lanes 3 and 4 (b)) but
proteins which are binding non-specifically to the Protein A tag. One cannot rule out
that because there are a number of proteins that are non-specifically binding to the Pra
tag, the identification of any specifically-bound proteins that are complexed to the
Secl8p are being masked and cannot readily be identified. On repeating this
purification a number of times novel protein bands would sometime appear that
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seemed to be specific to the Secl8pra fusion protein. However these results were
inconsistent and unreproducible. The absence of ATP within the wash buffer may
have contributed to the instability of proteins complexed to Seel 8pra upon the column.
This could be investigated by having a large excess of ATP or an ATP regenerating
systen present within the TST buffer during the wash procedure.
Procedure II : An affinity purification technique has recently been reported for the
isolation of membrane receptors that are responsible for the recognition and docking of
the 20S fusogenic complex onto membranes from bovine brain cytosol (Sollner et
al., 1993a). This procedure used the observation that in cell free transport systems the
20S complex was membrane associated in the presence of either ATPyS or of ATP in
the absence of any magnesium, and the complex dissociated on the addition of
magnesium. A similar approach was attempted using the Secl8pra fusion construct
and the control Pra protein as shown in Figure 3.5(a) and (b).
Comparing lanes 1 and 2 (Figure 3.5(a) ) it can be seen that the addition of
magnesium ions led to the elution of a large number of proteins but that these proteins
are not specific to Secl8p but rather seem to bind non-specifically to the Pra control
also. The fusion protein and Pra control are not eluted in this magnesium wash step as
shown in lanes 5 and 6 ofFigure 3.5(b). This non-specific binding of proteins to
the Pra tag is also observed in lanes 3 and 4 of the low pH washed material in (a) this
also contains the fusion protein and control Pra as detected in (b) in lanes 7 and 8.
There is still the possibility that small amounts of specifically bound proteins are being
eluted in the magnesium wash conditions but cannot be detected against a high
background of non-specifically bound proteins. To address this question the material
eluted by the addition ofmagnesium was analysed for the presence of wild-type
Secl8p and Secl7p using affinity-purified polyclonal antibodies. As shown in
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Figure 3.6 Secl8p was shown to be specifically attached to the fusion protein and
was not detected in the corresponding Pra control sample. Previous analysis has
shown that this material does not contain any fusion construct or related degradation
products (Figure 3.5(a)) therefore this signal may originate from two other sources;
(a) wild-type Secl8p complexed to the Secl8pra fusion protein as part of an active
fusogenic complex or (b) association of wild-type Secl8p with the Secl8pra fusion
protein in inactive protein aggregates. However, if the fusion protein was binding to
the wild-type protein in aggregates it would soon 'mop up' the wild-type protein and
the cell would eventually die which is not the case. To confirm the presence of an
active complex within the bound material an affinity purified polyclonal antibody was
used to identify the presence of Secl7p which has been shown to be involved within
the 20S fusogenic complex. However no detectable amounts of Secl7p were present
in the magnesium wash material. The lack of Secl7p may be due to the small amounts
of this protein present within the bound material compounded by the low titre of the
Secl7p antibody compared to that of the Secl8p antibody (see Appendix to
Chapter 3).
3.6 Conclusion
In this chapter I have described the construction of two gene fusions, one encoding a
fusion protein consisting of the yeast Secl8p carrying a C-terminal tag of two and a
half IgG binding domains of Protein A from S. aureus and the other encoding a Pra
control protein, in yeast vectors containing the strong GAL1 promoter. Although the
intracellular distribution of the fusion protein was slightly different from that reported
for Secl8p a proportion of Secl8pra did associate with both the high speed soluble
(S100) and membrane fractions (P100) as described for the wild-type protein. The in
vivo activity of the Secl8pra fusion protein was stongly suggested by the finding that
it complemented a sec!8-l mutation at the restrictive temperature. Initial attempts to
purify complexes containing the Secl8pra fusion protein revealed that the Pra tag itself
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bound a number of proteins nonspecifically and so made the identification of Sec 18
specific proteins impossible.
Identification ofwild-type Secl8p within the affinity purified material was done using
polyclonal antibodies raised against Secl8p. The presence of this Secl8p suggests
that the tagged version of Secl8p is interacting with the wild-type protein possibly
within mixed tetramers which can further interact in the proposed fusogenic complex.
Unfortunately the presence of Secl7p could not be detected within the same material.
Figure 3.1 Insertion of an Fspl site into the SEC18 gene by site
directed mutagenesis
The complete ORF of the SEC18 gene was cloned as a ScaVHindlU fragment from the
plasmid pSEY8 into the vector pK18 (digested with HincUJHindlYl). The SEC18
gene could then be subcloned into the phage vector M13mpl8 as a BamHl/Hindlll
fragment to give the plasmid M13SEC18 . The oligonucleotide 5'-AATTATGCG£A
TTGGGTCA-3' containing a single base substitution was used to anneal to the
ssDNA derived from the phage M13SEC18 and incorporate a new Fspl site to give the
plasmid Ml3SEC18(FspT). The introduction of this site was confirmed by restriction
enzyme analysis of the double stranded replicative form of DNA and by single-
stranded DNA sequencing.
Thr Gin Ser Ala Stop
5' TG ACC CAA TCC GCA TAA TT 3'
3' AC TGG GTT A£G CGT ATT AA 5'
Mutagenesis
Thr Gin Cys Ala Stop
5' TG ACC CAA TGC GCA TAA TT 3'
3' AC TGG GTT ACG CGT ATT AA 5'
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Table 3.1 Complementation of the seel8-1 mutation by a Secl8pra
fusion protein. Yeast strains were patched and grown on agar plates on the
appropriate selective medium. Patches were replica plated onto glucose and galactose
selective medium and grown at 25°C and 37°C and growth monitored visually. 'V'
indicates strong growth of the yeast cells. 'X' indicates no growth of yeast cells and
'slight' indicates weak growth of yeast cells.
25°C 37°C
STRAIN Growth on Growth on Growth on
glucose media glucose media galactose media
CHY01 V X X
CHYOl(pCHl) V slight slight
CHY01(pCH2) V slight slight
CHY01(pCH3) V slight V
CHY01(pCH4) V slight V
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Figure 3.2 Fractionation profile of Secl8pra fusion protein in the
presence / absence of ATP
Fractionation analysis was carried out on the yeast strain JRY188 transformed with
plasmids pCH3 and pCH4 in the presence or absence of ATP and called
JRY188(pCH3) and JRY188(pCH4). Yeast cultures were grown overnight to an
OD600 of 0.8 then the cells were harvested, washed once with 0.1 M Tris.HCl pH7.4
then resuspended in an appropriate volume of lysis buffer +/- ATP (5 mM ATP, 5 mM
MgCl2) and lysed using glass beads. The crude yeast lysate was centrifuged at 3,000
x g (P3) to remove any unbroken cells and the supernatant was pelleted sequentially at
12,000 x g (P12) and 100,000 x g (P100,S100). A sample of each fraction was run
on a 12% SDS PAGE and the presence of the fusion protein within each fraction
detected by Western blot analysis using a rabbit anti-bovine IgG HRP conjugate at a
1:10,000 dilution for 20 min. Detection was carried out on this blot using Enhanced
Chemiluminescence (ECL).
(a) LANES 1 to 4 contain the fractions P3, P12, P100, S100 respectively from the
yeast strain JRY188(pCH3) prepared in the absence of ATP. LANES 5 to 8 contain
the identical samples prepared in the presence of ATP.
(b) LANES 1 to 4 contain the fractions P3, P12, S100, P100 respectively from the
yeast strain JRY188(pCH4) prepared in the absence of ATP. LANES 5 to 8 contain
the identical samples prepared in the presence of ATP.
(c)To resolve the two isoforms of the Secl8pra fusion the P100/S100 fractions were
analysed on a 7.5% SDS PAGE. LANES 1 to 3 show the P100, S100, and
P100/S100 mixed samples from JRY188(pCH3) whereas LANES 4 to 6 contain












Figure 3.3 Fractionation profile of the Secl8pra fusion protein under
various conditions
Yeast strain JRY188(pCH3) was grown in galactose selective medium to an OD600 of
0.8. The culture was harvested and lysed using glass beads. TheP12andS12
fractions were prepared using (a) normal lysis buffer (b) lysis buffer containing 0.1 M
NaHC03 at pH12.5 or (c) lysis buffer containing 2.5 M urea. The S12 fractions were
then subjected to further fractionation by differential centrifugation giving a high speed
membrane pellet (P100) and supernatant (S100). The distribution of the fusion
protein under these conditions was analysed by a 10% SDS PAGE followed by
Western blot analysis. The fusion protein was detected using a rabbit anti-bovine IgG
HRP conjugate antibody at a 1:10,000 dilution. The Western blot was developed
using ECL.
LANE 1 : P100/S100 fractions under normal lysis conditions
LANE 2 : P100/S100 fractions from 0.1 M NaHC03 treated extracts
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69
Figure 3.4 Affinity purification of Secl8pra fusion protein from yeast
in the presence of an ATP regenerating system
The yeast strains JRY188(pCH3) and JRY188(pCH5) were grown in SGtrp" selective
medium at 30°C to an O.D60o of 0.8. The cells were harvested and split into two
equal samples which were resuspended in 250|ll of Buffer A (200 mM Tris.HCl
pH7.4; 2 mM EDTA pH8.0; 4 mM PMSF; 200|i.gmT1 pepstadn, antipain, leupeptin
and chymostatin and an ATP regenerating system (1 mM ATP pH7.0 (with NaOH), 8
mM creatine phosphate, 40(i.gml"1 phosphocreatine kinase ) or Buffer B(as Buffer A
but without the ATP regenerating system). Samples were lysed using glass beads and
centrifuged at 12,000xg for 15 min and the supernatant retained (S12). These extracts
were added to 0.7ml of IgG Sepharose (dry volume) which had been prewashed in
TST buffer (50 mM Tris.HCl pH7.4; 150 mM NaCl and 0.05% Tween 20) and were
then incubated at 4°C for 2hr on a rotating wheel. The material was then transferred
into a 'Poly-Prep' column and unbound material was removed by washing with 10X
column volume of TST buffer until the A2so of the unbound wash was zero. Elution
of the fusion protein and Pra was done by adding 2ml of 0.5 M acetic acid pH3.4 to
the column. This eluted material was dialysed against distilled water, freeze dried
overnight then resuspended in 30jil of water and stored at -70°C. 10(il of each
sample was loaded onto two 10% SDS PAGE and either (a) silver stained or (b)
analysed by Western blot.
(a) LANE 1 Secl8pra binding in the absence of an ATP regenerating system.
LANE 2 Secl8pra binding in the presence of an ATP regenerating system.
LANE 3 Pra control binding in the absence of an ATP regenerating system.
LANE 4 Pra control binding in the presence of an ATP regenerating system.
LANE 5 Mixture of samples loaded in lanes 1 and 3.
LANE 6 Mixture of samples loaded in lanes 2 and 4.
(b) The lanes are exactly the same as those in (a) but proteins were analysed by
Western blot analysis, using a rabbit anti-bovine IgG peroxidase conjugate.
70
(a)

















Figure 3.5 Affinity purification of the Secl8pra fusion protein from
yeast in the presence of ATP without any magnesium
Yeast strains JRY188(pCH3) and JRY188(pCH5) were grown overnight at 30°C in
600 ml of SGtrp" selective medium to a final O.D600 of 0.8. Cells were harvested,
washed once in 0.1 M Tris.HCl pH7.4 and resuspended in a modified lysis buffer:
25 mM Tris.HCl pH7.4; 0.75% (w/v) Triton X100; 75 mM KC1; 2 mM EDTA; 0.5
mM ATP; 1% polyethylene glycol (PEG) 4000; 200 (igmT1 each of pepstatin,
leupeptin, antipain and chymostatin and 4 mM PMSE. They were then lysed using
glass beads and a S12 extract was prepared. Extracts containing half the original cells
were added to 0.7ml of IgG Sepharose (dry volume) previously washed in the same
lysis buffer and incubated at 4°C for 2 hrs on a rotating wheel. This material was then
transferred into a 'Poly-Prep' column which was washed to remove any non-
specifically bound proteins with 10X column volume of wash buffer: 20 mM
Tris.HCl pH7.4; 0.5% (w/v) Triton X100; 100 mM KC1; 2 mM EDTA and 0.5 mM
ATP. Specific complexes were disassembled using 5 ml of elution buffer: Wash
buffer plus 8 mM MgCl2. Both the fusion protein and the Pra control were then eluted
from the column using 5 ml of 0.2 M Glycine pH 2.8. The samples eluted from the
column using the elution buffer and the low pH buffer were freeze dried overnight and
resuspended in 200 (il of distilled water and stored at -70°C. 15 (il of each sample
was analysed by SDS PAGE on a 12% gel as shown in
(a) LANE 1: Elution buffer eluant from Sec 18pra column.
LANE 2: Elution buffer eluant from Pra control column.
LANE 3: Low pH buffer eluant from Secl8pra column.
LANE 4: Low pH buffer eluant from Pra control column.
(b) The other half of the gel containing samples from the same eluants in LANES 5 to
8 were transferred onto a nitrocellulose membrane for Western blot analysis. The
presence of pra was detected using the primary antibody a rabbit anti-bovine IgG















Figure 3.6 Analysis of bound material for presence of the wild-type
Secl8p and Secl7p
The Mg++ eluants from both the Secl8pra and Pra affinity columns were analysed
further by Western blot for the presence of Secl8p and Secl7p. 1 5jll1 of the samples
were loaded on 12% SDS polyacrylamide gels and transferred to nitrocellulose. These
membranes were probed with an affinity purified Secl8p or Secl7p polyclonal
antibody in an overnight incubation with a dilution of the primary antibody of 1:100.
Detection of this signal using ECL was performed after the membranes had been
incubated for 20 min at a 1:5,000 dilution of a second donkey anti-rabbit IgG
peroxidase conjugate antibody. The Western blot shown is that which was incubated
with the Secl8p specific polyclonal antibody as no Secl7p could be detected in the
Mg++ eluants.
LANE 1: Elution buffer eluant from Secl8pra column.
LANE 2: Elution buffer eluant from Pra control column.
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Appendix to Chapter 3
3.A.1 Production of affinity purified antibodies against Secl8p and
Seel7p
During the course of this work polyclonal antibodies were raised against both Secl8p
and Secl7p. Both of these antibodies were used for identification of these proteins in
the affinity purified material from yeast using the SeclSpra fusion protein to see if the
correct complex was being isolated (Chapter 3). In both cases a fusion between the
gene encoding Protein A from S. aureus and either the SEC18 gene or the SEC17
gene was constructed in the plasmids pCH18 and pCH20 respectively. These fusion
constructs were then expressed and purified by affinity chromatography from bacterial
cells using Fast Flow IgG Sepharose and used for the immunization of rabbits (see
Materials and Methods). Protein A fusions have been reported to give good immune
responses (Lowenadler et al., 1986), possibly due to the repetitive globular units of
the protein A moiety.
Affinity purification of specific Secl8p and Secl7p antibodies was carried out as
described in Materials and Methods using an analogous second set of fusions between
the gene encoding [3-galactosidase and either the SEC18 gene (pCH19) or the SEC17
gene (pCH21). Affinity purified Secl8p and Secl7p antibodies were shown to
recognise proteins of the correct molecular size of 82 kDa and 84 kDa in the case of
Secl8p and 33 kDa in the case of Secl7p in lysates prepared from both wild-type and
over-expressing yeast strains as shown in Figure 3.A. 1 and Figure 3.A.2. Two
major degradation products are observed for the wild-type Secl8p which are not seen
in the case of the Secl8pra fusion protein used in Chapter 3. It may be that the Pra tag
of the fusion protein somehow stabilises the Secl8p in vivo possibly protecting
Secl8p from C-terminal degradation. As can be seen from Figure 3.A.2 the titre of
the Secl7p antibody is much lower than that observed for the Secl8p antibody.
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Figure 3.A.1 Detection of Secl8p by affinity purified polyclonal
antibodies.
A low speed supernatant (SI2) was prepared from the wild-type yeast strain JRY188,
and the transformed strain JRY188(pCH7), which has the SEC18 gene under the
control of the GAL1 promoter, after growth on galactose medium and fractionated by
SDS PAGE on a 10% gel. The proteins were transferred to nitrocellulose and the blot
was analysed by Western analysis using, as first antibody, affinity purified anti-
Sec 18p antibodies (see Materials and Methods for production) at a 1 : 100 dilution
overnight. The second antibody was a donkey anti-rabbit IgG-HRP conjugate used at
a 1 : 5,000 dilution for 20min and was detected was using ECL.
LANE 1 : S12 extract from wild-type strain JRY188.
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Figure 3.A.2 Detection of Secl7p by affinity purified polyclonal
antibodies.
A low speed supernatant (SI2) was prepared from the wild-type yeast strain JRY188,
and the transformed strains JRY188(pCH22) and JRY188(pCH22A) which are
expected to have low and high expression levels of the Secl7p respectively. Samples
were fractionated by SDS PAGE on a 15% gel, the proteins were transferred to
nitrocellulose and the blot was analysed by Western analysis using, as first antibody,
affinity purified anti-Sec 17p antibodies (see Materials and Methods for production) at
a 1 : 100 dilution overnight. The second antibody was a donkey anti-rabbit IgG-HRP
conjugate used at a 1 : 5,000 dilution for 20min and was detected using ECL.
LANE 1 : S12 extract from wild-type strain JRY188.
LANE 2 : S12 extract from yeast strain JRY188(pCH22).
LANE 3 : S12 extract from yeast strain JRY188(pCH22A).
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LANE 12 3 kDa
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Chapter 4
Random mutagenesis of the SEC18 gene and
isolation of dominant negative alleles of this gene
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4.1 Introduction
A number of genetic strategies have been successfully applied v/ithin yeast in an
attempt to elucidate the steps of vesicle mediated transport. The isolation of yeast
mutants defective in protein secretion (sec mutants), retention of soluble ER proteins
(erd mutants), or sorting of vacuolar proteins (vps mutants) has allowed the
identification of a number of genes which act at different stages of the secretory
pathway (Novick eta!., 1980, Pelham etal., 1988, Banta etal., 1988). A functional
relationship between proteins may be indicated when two defective mutants have a
lethal phenotype as a double mutant showing synthetic lethality, or the genetic defect
of one mutant is suppressed by another gene. No extragenic suppressors of the
original secl8-l temperature sensitive allele have been isolated (T. Graham, personal
communication ). This chapter introduces an alternative genetic strategy taken to
identify novel proteins that may interact with the SEC18 gene product.
The SEC18 gene encodes two gene products of approximately 82 kDa and 84 kDa
(Eakle et al., 1988). These polypeptides are thought to form an active tetramer
involved in vesicle transport. A dominant negative mutant (DNM) form of the
SEC18 gene will encode mutant Secl8p monomers which should interact with and
inhibit the normal function of the wild-type protein in vivo in a number of ways
(Herskowitz, 1987). Mutant forms of Secl8p could show 'internal dominance' by
forming mixed tetramers with the wild-type polypeptide giving non-functional
tetramers that cannot interact with other 'target' proteins during normal Secl8p
function. 'External dominance' would result when potentially active mixed tetramers
interact with specific target proteins but in a non-functional way by forming either
unstable fusion complexes or complexes that are locked into a non-functional form.
Alternatively, the aberrant Secl8p tetramer could lose the normal specificity observed
for fusion with a target vesicle and so promote deleterious targeting / fusion events
within the yeast cell. This chapter gives a description of the strategies used to mutate
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the SEC18 gene and screen for genes encoding DNM forms of the Secl8p. An initial
analysis of two of the mutants shows the extent to which the SEC18 gene in each case
was mutagenised.
4.2 Insertion of the SEC18 gene downstream of the GAL1 promoter
within yeast expression vectors
To regulate the expression of Secl8p within yeast cells the gene was first cloned into a
low copy yeast expression vector YCpGAL. The SEC18 gene was cloned as a 3.0
kbp BamHl/Hindlll fragment from the vector pSEY8 into the BamHl/Hindlll sites of
YCpGAL to produce the construct pCH7. The SEC18 gene was inserted downstream
of the strong GAL1 promoter allowing the expression of deleterious gene products to
be conditional on the presence of galactose and repressed by the presence of glucose in
the growth medium.
4.3 Random mutagenesis of the SEC18 gene and screening for
dominant negative mutations within the SEC18 gene
Since the sites of interaction between Secl8p and other proteins within the proposed
fusion complex have not been characterised a random mutagenic approach was
adopted. Two strategies were used; in vitro polymerase chain reaction (PCR)
mutagenesis and in vivo mutagenesis using a mutD strain of E. coli. PCR
mutagenesis is based upon a normal reaction carried out under sub-optimal conditions
with respect to cation concentrations and a bias in nucleotide concentrations (see
Materials and Methods). This decreases the fidelity of replication by Tciq polymerase
during amplification of the DNA fragment. The mutD strain of E. coli contains a
mutated e subunit of DNA polymerase III affecting the 3' —» 5' exonuclease activity
of this enzyme and so interfering in the proof-reading ability within the bacterial strain
during DNA replication (see Materials and Methods).
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The amplified DNA resulting from the mutagenic PCR reaction was cotransformed
with a gapped yeast expression vector (YCpGAL) into an appropriate yeast strain.
This resulted in the insertion of the PCR products into the gapped plasmid by
homologous recombination events in vivo (as shown in Figure 4.1.) and allowed
the direct screening for mutants within the yeast strain. The mutD mutagenesis
however produced a mutagenised pool of plasmid DNA which had to be transformed
into the appropriate yeast strain (JRY188 or CHY01) for screening purposes. In both
cases individual yeast transformants were isolated and screened by replica-plating of
patched colonies onto various growth media at different temperatures.
The yeast strain CHY01 which contains the temperature sensitive sec!8-l allele was
used to measure the amount of mutagenesis incurred under the three mutagenic
conditions. This strain does not grow at the nonpermissive temperature of 37°C.
When transformed with DNA from a mutagenic reaction the transformants will either
grow at 37°C on medium containing galactose due to production of a wild-type gene
product which complements the ts defect, or will show no growth under these induced
conditions if an inactive mutant gene product is being expressed. As seen in Table
4.1. a high proportion of ts phenotype is observed when using PCR mutagenesis
compared to the mutD strategy.
As described previously, a DNM form of the Secl8p should interact in a negative way
with wild-type Secl8p when induced by the presence of galactose as a carbon source
in the growth medium . This interaction should affect the ability of the wild-type
Secl8p to participate in membrane fusion/docking events occurring throughout the
secretory pathway. As such, the growth of the transformed yeast cells is expected to
be normal in glucose media but should be decreased in galactose media due to the
induced DNM form of Secl8p interfering with the wild-type polypeptide function.
The yeast strain JRY188 which is SEC18 + was used to screen for the DNM
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phenotype (.Figure 4.2.).
A total of 3000 transformed colonies resulting from experiments using three methods
were screened giving an initial pool of 32 potential DNM forms of the SEC18 gene,
however on rechecking of the phenotype and selection for absolute galactose-
sensitivity the pool was restricted to 5 showing a plasmid dependent DNM phenotype
(see Table 4.1.). The plasmids were recovered from galactose-sensitive
transformants by preparing total DNA from the 5 individual colonies. This DNA was
then transformed into the E. coli strain NM522, and the plasmids which represent 5
DNM forms of the SEC18 gene were recovered; 2 originating from the mutD
mutagenesis and 3 from the PCR mutagenesis. The mutagenised SEC18 gene was
cloned from these plasmids in each case as a BamHl/HindLll cassette into a new
YCpGAL yeast expression vector and the phenotype rechecked in the yeast strain
JRY188. The constructs were named pCH8, 9, 10, 11 and pCH12 and contained
SEC18-108, 109, 110, 111and 112 DNM alleles respectively.
4.4 Analysis of mutations within the SEC18 gene
To get an idea as to the extent ofmutagenesis obtained by both strategies two of the
isolates were sequenced, one originating from the mutD mutagenesis (SEC18-109)
and the other from PCR mutagenesis (SEC18-112). These particular alleles were
chosen because the phenotype of yeast strains harbouring them has been characterized
extensively and has been shown to be very different (see Chapter 5). Since the gene
products produced from these alleles have such different effects in vivo sequence
analysis may give some information as to the important residues that are responsible
for the dominant negative phenotype seen in vivo.
The sequencing strategy involved a number of oligonucleotides specific to the wild-
type SEC18 gene as shown in Figure 4.3. The sequences of the two mutants
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(SEC18-109 and SEC18-112) were compared with that obtained on resequencing the
wild-type SEC18 gene which had been used as the original template for mutagenesis.
On resequencing this wild-type SEC18 gene an extra codon (GTG) was identified
between the original codons GAT1679 and GTT1682 as defined in the SEC18 gene
sequence cloned by Eakle et al., 1988. This extra codon identified within this work as
GTG j 682 encodes an additional glycine residue in the amino acid sequence of Secl8p
(see Figure 4.3.). This Gly residue is predicted to be present in both the recently
identified Secl8p from Candida albicans (Nieto et al., 1993) and the mammalian NSF
protein (Wilson et al., 1989) and another group has recently resequenced the SEC18
gene as part of the yeast genome project and submitted the revised sequence to the
EMBL database library (Van der Aart et al., 1994).
The type and number of mutations observed in these two mutants is summarised in
Table 4.2. PCR mutagenesis has mutated the SEC18 gene to the greatest extent:
The type of base changes shown in the SEC18-112 allele mainly being A/T, the most
abundant of which are A/T—> G/C transitions. This has resulted in 0.5%
mutagenesis of the ORF of the SEC18 gene although all of these mutations are not
relevant at the amino acid level and therefore only 1% of the Secl8p is in fact
mutagenised by this method. The mutD strategy however shows a much lower degree
of mutations in the SEC18-109 allele of 0.04% at the nucleotide level and 0.1% at the
amino acid level. It is worth noting that the mutations seen in both mutant alleles do
not occur within the proposed ATP binding sites of the SEC18 gene.
4.5 Further analysis of the SEC18-112 mutant allele
Although twelve mutations were found within the SEC18-112 mutant only eight of
these are relevant at the amino acid level and therefore could be responsible for the
DNM phenotype observed within strains harbouring this allele. To try and identify the
residues which are important in retaining the wild-type Secl8p phenotype and may
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contribute to the DNM phenotype when mutated, a 'hybrid domain' strategy was
adopted. As shown in Figure 4.4 (a) the SEC18-112 allele can be divided into
three regions (N region, M region and C region) which contain a number of relevant
mutations, using restriction endonucleases. The positions of each restriction
endonuclease are as shown in Figure 4.3. This allows chimaeric proteins to be
made by cloning the wild-type SEC18 sequence in to replace each domain separately
producing hybrids that can then be expressed within the yeast strain JRY188 and the
phenotype analysed. It is shown in Figure 4.4(b)that on replacing the C region of
SEC18-112 with a wild-type SEC18 sequence the gene still encodes a protein which
has a DNM phenotype on galactose medium, whereas replacing either the N or M
region results in the expression of a protein that does not exhibit a DNM phenotype.
From these initial observations it seems that the three mutations within the C region of
the SEC18-112 allele are not responsible for the DNM phenotype seen within strains
harbouring this allele. Thus the mutations responsible for the DNM phenotype may be
localised to six mutations within the N and M regions of the gene but at this point it is
not known if all of these mutations are relevant or contribute equally to the DNM
phenotype observed.
4.6 Further analysis of the SEC18-109 mutant allele
Only one mutation was observed within this mutant allele resulting in the alteration of
Thr394 to Pro and the expression of a DNM phenotype on galactose medium. This
mutation does not occur in either of the proposed ATP binding sites within the Secl8p
sequence (Figure 4.3). The structure of the Secl8p, and therefore the regions
which are in contact with other proteins within the proposed fusion complex, is as yet
unknown, however as shown in Figure 4.5 the altered Thr394 residue is within a
highly conserved region between NSF, Secl8p from Candida albicans and the Secl8p
from S. cerevisiae suggesting that this residue may be important either structurally or
functionally within the protein. Does this amino acid change alter the predicted
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secondary structure of the Secl8p? Using a secondary-structure prediction based on
the combination of several separate methods (Sawyer et al., 1986) it can be seen that
there is no obvious alteration to the structure at this level and a (3-strand is predicted
within this region for both the wild-type and mutant protein (as shown in Figure
4.6) .
4.7 Conclusion
Within this Chapter I have described two methods of random mutagenesis which I
have used to mutate the SEC18 gene of S. cerevisiae and identify 5 DNM mutant
alleles of this gene (SEC18-108.109, 110, 111 and 112). Sequence analysis of the
SEC18 gene revealed an extra codon which was not identified within the original
sequence. Two mutant alleles were also sequenced; SEC18-109 (resulting from
mutD mutagenesis) and SEC18-112 (resulting from PCR mutagenesis). SEC18-109
contains one mutation which results in a single amino acid change of a highly
conserved Thr residue which results in a mutant Secl8p that is responsible for the
observed DNM phenotype in vivo. The exact role of this residue within the structure
of Secl8p is not yet known although initial studies show that this residue does not
change the secondary structure of the protein significantly. SEC18-112 however
contains eight mutations at the amino acid level, and initial analysis has shown that the
first six of these mutations may be responsible for the DNM phenotype of this protein
in vivo.
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Figure 4.1 Cotransformation of muutagenised SEC18 gene and
a gapped plasmid into the yeast strain JRY188.
The oligonucleotides 5'- GCTCACTCATTAGGCACC -3' and 5'-CCGCACA
GATGCGTAAGG -3' were used to anneal to pCH7 and produce a PCR
product of approximately 4.1 kbp containing the GALSEC18 cassette. The
mutagenic PCR reaction conditions were first optimised for MgCl2
concentration at 5 mM. Either 0.4 mM or 0.6 mM MnCl2 was used giving a
ratio of 8 : 1 or 12 : 1 of Mg++ to Mn"14" ions respectively in the PCR reaction.
The resultant PCR reaction mixture contains a population of wild-type and
mutagenised DNA fragments.
This reaction mixture was cotransformed with the plasmid YCpGAL (gapped
with BamHl/Hindlll) into the yeast strain JRY188. Homologous
recombination in vivo repairs the plasmid with the PCR product thus
producing yeast transformants carrying individual plasmids expressing a wild-





I. Mutagenise GALSEC18 by PCR
2. Recombine PCR product with





3. Screen Trp+transformants for dominant
negative phenotype.
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Table 4.1 Extent of mutagenic phenotype observed for three random
mutagenic strategies.
Method of Number of
mutagenesis colonies
screened
% of CHY01 transformants
not able to complement
the sec!8-l defect at 37°C
% of JRY188
transformants not







PCR 12 : 1 56 45 16
8 : 1 77 22
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Figure 4.2. Screening for a dominant negative Secl8p
phenotype in the yeast strain JRY188.
The yeast strain JRY188 was cotransformed with (a) PCR amplified DNA and
a gapped YCpGAL plasmid (as described in Figure 4.1.) or (b) transformed
with a mutagenised DNA pool obtained from the mutD mutagenesis (see
Materials and Methods). The resultant Trp+ transformants were plated out
onto SDTrp" (glucose) plates and grown at 25°C. Individual colonies were
picked and patched onto fresh SDTrp" plates at 25°C. These yeast patches
were replica-plated onto both glucose (SD) and galactose (SG) selective plates
and growth was monitored at 25°C and compared to patches of the yeast strain



















Figure 4.3 Revised sequence of the SEC18 gene and the
predicted amino acid sequence
The wild-type SEC18 gene and two mutant alleles (SEC18-109 and SEC18-
112) carried on plasmids pCH7, pCH9 and pCH12 respectively were
sequenced using standard double stranded plasmid sequencing (see Materials
and Methods) using SZTC/S-specific primers corresponding to the + strand of
DNA. The direction of the oligonucleotides are shown as single arrows and
only one strand was sequenced. An additional codon encoding a Gly residue
was identified and is highlighted in bold and the two consensus sequences for
ATP binding are boxed. The position of the restriction sites: BamWl
[gIjATCC]; Bsml [GAATGCC]; Nrul [TCGCGA] and //mdlll [AAGCTT]
are underlined. The numbering of the nucleotide and amino acid sequences
were subsequently modified from that of the original published SEC18














































Met Phe Lys lie Pro Gly Phe Gly Lys Ala Ala Ala Asn His Thr Pro Pro
ATG TTC AAG ATA CCT GGT TTT GGA AAA GCT GCT GCA AAT CAT ACT CCA CCA
Asp Met Thr Asn Met Asp Thr Arg Thr Arg His Leu Lys Val Ser Asn Cys
GAT ATG ACA AAC ATG GAT ACC CGT ACA CGC CAT TTA AAG GTG TCA AAC TGT
Pro Asn Asn Ser Tyr Ala Leu Ala Asn Val Ala Ala Val Ser Pro Asn Asp
CCA AAT AAC TCC TAT GCA CTC GCA AAC GTA GCT GCT GTC TCA CCA AAT GAT
Phe Pro Asn Asn lie Tyr lie lie lie Asp Asn Leu Phe Val Phe Thr Thr
TTC CCT AAT AAC ATT TAT ATT ATT ATC GAT AAT TTA TTT GTT TTC ACA ACT
Arg His Ser Asn Asp lie Pro Pro Gly Thr lie Gly Phe Asn Gly Asn Gin
AGA CAC TCC AAC GAC ATT CCA CCG GGA ACC ATT GGA TTT AAC GGT AAC CAG
Arg Thr Trp Gly Gly Trp Ser Leu Asn Gin Asp Val Gin Ala Lys Ala Phe
CGT ACC TGG GGT GGT TGG TCC CTA AAT CAA GAC GTG CAA GCA AAA GCA TTT
Asp Leu Phe Lys Tyr Ser Gly Lys Gin Ser Tyr Leu Gly Ser lie Asp lie
GAT TTA TTC AAG TAT TCC GGT AAG CAA TCG TAT CTT GGT TCA ATA GAT ATA
Asp lie Ser Phe Arg Ala Arg Gly Lys Ala Val Ser Thr Val Phe Asp Gin
GAT ATC TCA TTC AGA GCT AGA GGT AAG GCG GTA AGC ACG GTA TTC GAT CAA
Asp Glu Leu Ala Lys Gin Phe Val Arg Cys Tyr Glu Ser Gin lie Phe Ser
GAT GAG TTA GCC AAA CAA TTT j^TT CGT TGC TAC GAA TCT CAA ATA TTT TCT
Pro Thr Gin Tyr Leu lie Met Glu Phe Gin Gly His Phe Phe Asp Leu Lys
CCC ACC CAG TAC CTT ATC ATG GAG TTC CAA GGC CAT TTC TTT GAC TTA AAA
lie Arg Asn Val Gin Ala lie Asp Leu Gly Asp lie Glu Pro Thr Ser Ala
ATT AGA AAT GTC CAA GCA ATC GAT TTG GGT GAT ATT GAA CCA ACC TCC GCT
Val Ala Thr Gly lie Glu Thr Lys Gly lie Leu Thr Lys Gin Thr Gin lie
GTT GCA ACT GGG ATA GAG ACA AAG GGA ATT TTG ACA AAA CAA ACA CAA ATT
Asn Phe Phe Lys Gly Arg Asp Gly Leu Val Asn Leu Lys Ser Ser Asn Ser
AAT TTT TTC AAA GGA AGA GAT GGT TTA GTT AAT TTG AAA TCA TCA AAT; TCA
Leu Arg Pro Arg Ser Asn Ala Val lie Arg Pro Asp Phe Lys Phe Glu Asp
TTA AGA CCA AGA TCA AAT GCT GTG ATC AGA CCG GAT TTC AAG TTT GAA GAT
Leu Gly Val Gly Gly Leu Asp Lys Glu Phe Thr Lys lie Phe Arg Arg Ala
TTG GGT GTC GGT GGT TTG GAT AAA GAG TTT ACT AAA ATT TTC AGA AGA GCG
Phe Ala Ser Arg lie Phe Pro Pro Ser Val lie Glu Lys Leu Gly lie Ser
TTT GCA AGT CGA ATC TTT CCT CCT TCA GTT ATA GAA AAA CTG GGT ATT TCT
His Val Lys
CAT GTT AAA
lie Ala Arg Lys lie Gly Thr Met Leu Asn Ala Lys Glu Pro Lys lie Val
ATT GCA AGA AAG ATT GGT ACA AJG CTG AAT GCC AAA GAG CCC AAA ATC GTC
Asn Gly Pro Glu lie Leu Ser Lys Tyr Val Gly Ser Ser Glu Glu Asn lie
AAT GGT CCA GAA ATT TTG AGT AAG TAC GTT GGT TCT TCA GAA GAA AAC ATT
Arg Asn Leu Phe Lys Asp Ala Glu Ala Glu Tyr Arg Ala
CGT AAT TTA TTT AAG GAT GCA GAA GCA GAA TAT AGG GCC
Lys Gly Glu Glu
AAG GGT GAG GAA
Ser Ser Leu His lie lie lie Phe Asp
TCT TCC TTA CAT ATT ATT ATT TTC GAT
Glu Leu Asp Ser Val Phe Lys Gin
GAG CTG GAT TCT GTT TTC AAG CAG
Arg Gly Ser Arg Gly Asp Gly Thr Gly Val Gly Asp Asn Val Val Asn Gin
AGA GGT TCA AGA GGT GAT GGT ACC GGT GTA GGG GAC AAJ GTA GTT AAT CAA
Leu Leu Ala Lys Met Asp Gly Val Asp Gin Leu Asn Asn lie Leu Val lie
TTG TTA GCT AAA ATG GAT GGT GTT GAT CAA TTG AAT AAT ATT TTG GTT ATT
Gly Met Thr Asn Arg Lys Asp Leu lie Asp Ser Ala Leu Leu Arg Pro Gly
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Arg Phe Glu Val Gin Val Glu lie His Leu Pro Asp Glu Lys Gly Arg Leu
AGA TTT GAA GTC CAA GTT GAA ATT CAT TTA CCC GAT GAA AAA GGA AGA CTC
Gin He Phe Asp lie Gin Thr Lys Lys Met Arg Glu Asn Asn Met Met Ser
CAA ATT TTC GAC ATT CAG ACG AAG AAA ATG AGG GAA AAT AAT ATG ATG AGC
Asp Asp Val Asn Leu Ala Glu Leu Ala Ala Leu Thr Lys Asn Phe Ser Gly
GAC GAT GTT AAC ITA GCT GAG TTA GCJ GCG TTA ACA AAA AAC TTC TCT GGT
Ala Glu lie Glu Gly Leu Val Lys Ser Ala Ser Ser Phe Ala lie Asn Lys
GCT GAG ATT GAG GGT TTA GTG AAG AGT GCA AGT TCT TTT GCA ATC AAC AAA
Thr Val Asn lie Gly Lys Gly Ala Thr Lys Leu Asn Thr Lys Asp lie Ala
ACC GTC AAC ATC GGG AAA GGT GCC ACA AAA CTT AAC ACT AAA GAT ATA GCA
Lys Leu Lys Val Thr Arg Glu Asp Phe Leu Asn Ala Leu Asn Asp Val Thr
AAA CTT AAA GTA ACA AGA GAA GAC TTT TTA AAT GCA CTC AAC GAT GTT ACT
Pro Ala Phe Gly lie Ser Glu Glu Asp Leu Lys Thr Cys Val Glu Gly Gly
CCC GCT TTT GGG ATT AGT GAA GAA GAT TTG AAA ACA TGT GTG GAA GGT GGA
Met Met Leu Tyr Ser Glu Arg Val Asn Ser lie Leu Lys Asn Gly Ala Arg
ATG ATG CTT TAJ TCC GAA CGA GTT AAC TCA ATA TTG AAG AAC GGA GCC CGT
Tyr Val Arg Gin Val Arg Glu Ser Asp Lys Ser Arg Leu Val Ser Leu Leu
TAC GTC CGC CAA GTT CGC GAG AGT GAT AAA TCC AGG TTA GTA TCT CTA TTA
lie His Gly Pro Ala Gly Ser Gly Lys Thr Ala Leu Ala Ala Glu lie Ala
ATC CAC GGC CCT GCA GGG TCC GGT AAA ACA GCT TTA GCC GCT GAA ATT GCT
Leu Lys Ser Gly Phe Pro Phe lie Arg Leu lie Ser Pro Asn Glu Leu Ser
TTA AAA TCT GGA TTC CCA TTC ATC AGG TTA ATT TCT CCC AAC GAG TTG TCA
Gly Met Ser Glu Ser Ala Lys lie Ala Tyr lie Asp Asn Thr Phe Arg Asp
GGC ATG TCA GAA AGC GCA AAA ATT GCC TAT ATT GAT hfyC ACT TTC AGA GAT
Ala Tyr Lys Ser Pro Leu Asn lie Leu Val lie Asp Ser Leu Glu Thr Leu
GCG TAT AAA TCT CCA CTA AAC ATT CTT GTT ATT GAT TCG TTA GAG ACT CTA
Val Asp Trp Val Pro lie Gly Pro Arg Phe Ser Asn Asn lie Leu Gin Met
GTT GAT TGG GTA CCA ATT GGT CCA AGA TTC TCT AAT AAC ATT TTA CAA ATG
Leu Lys Val Ala Leu Lys Arg Lys Pro Pro Gin Asp Arg Arg Leu Leu lie
CTA AAG GTT GCA TTG AAG CGT AAA CCC CCA CAA GAC CGT CGT TTA TTG ATC
Met Thr Thr Thr Ser Ala Tyr Ser Val Leu Gin Gin Met Asp lie Leu Ser
ATG ACT ACT ACA TCA GCT TAT TCG GTA CTT CAA CAA ATG GAT ATC TTG AGT
Cys Phe Asp Asn Glu lie Ala Val Pro Asn Met Thr Asn Leu Asp Glu Leu
XGC TTC GAC AAT GAG ATA GCA GTT CCA AAT ATG ACC AAT TTA GAT GAA TTG
Asn Asn Val Met lie Glu Ser Asn Phe Leu Asp Asp Ala Gly Arg Val Lys
AAC AAC GTC ATG ATA GAA TCA AAC TTT CTT GAC GAT GCT GGT AGA GTT AAA
Val lie Asn Glu Leu Ser Arg Ser Cys Pro Asn Phe Asn Val Gly lie Lys
GTT ATT AAT GAA TTA TCA AGG AGC TGT CCT AAC TTC AAT GTC GGT ATT AAA
Lys Thr Leu Thr Asn lie Glu Thr Ala Arg His Asp Glu Asp Pro Val Asn
AAG ACC TTG ACC AAC ATT GAA ACC GCA AGG CAC GAT GAA GAT CCC GTG AAC
Glu Leu Val Glu Leu Met Thr Gin Ser Ala Stop
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Figure 4.4 Construction and expression of hybrid genes
between the SEC18-112 gene and the wild-type SEC18 gene
Three hybrid constructs were made by cloning the wild-type SEC18 sequence
from plasmid pCH7 as a BamHl/Bsml (N region), Bsml/Nrul (M region) or
Nrul/HindUl (C region) into the corresponding sites within the SEC18-112
mutant allele carried on the plasmid pCH12. The positions of these restriction
sites within the SEC18 gene are shown in Figure 4.3. The resulting
constructs were named pCH23, 24 and 25 and were transformed into JRY188.
The transformed strains JRY188(pCH23 to 25) were grown in 10 ml of
glycerol / ethanol selective medium at 25°C until the culture was in mid-
exponential growth. At this point 3% (w/v) galactose was added to the
medium and the growth of the cultures was monitored for a further 5 hrs at
25°C.
(a) Schematic diagram showing the positions of the mutations within the three
regions of the SEC18-112 mutant allele.
(b) Graph showing the growth of transformed strains JRY188(pCH23 to 25)
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Figure 4.5 Sequence alignment between the S. cerevisiae
Secl8p, the C. albicans Secl8p and mammalian NSF
The amino acid sequence of the Secl8p from S. cerevisiae was aligned with
that of the Secl8p from C. albicans and the mammalian NSF sequence
respectively using the program 'pileup' on the 'U.W.G.C.G.' sequence
analysis package. The middle sequence shown is that of Secl8p from S .
cerevisiae and the symbol ' •' represents an identical sequence alignment of
this sequence with the C. albicans Secl8p sequence or the NSF sequence
respectively. The mutant allele SEC18-109 contains a Thr394 to Pro mutation
which can be seen as the boxed residue within this alignment and occurs in a
region which is highly conserved between these three proteins.
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C_Secl8p MEKLGFHKVS NSPSSPSQPK ITHNRPIPHP QSPPLPQRPL SEPLKKQLLV DNSPGNDWI ANCVAVNAQD FQNIPDRAPV
Secl8p ..MFKIPGFG KAAANHTPPD MTN MDTRTRHLKV SNCPNNSYAL ANVAAVSPND F...PNNIYI
Nsf MAGRSMQA ARCPTDELSL SNCAWSEKD YQSGQHVIVR
C_Secl8p ILDG.VFVYS IAKDDRVRPG TIGLAGNMRT WGKWSLGQPV NVENYNIFHN GQQQQYLGAI DLLIDFRAKA RANLNPINHD
Secl8p IIDN.LFVFT TRHSNDIPPG TIGFNGNQRT WGGWSLNQDV QAKAFDLFKY SGKQSYLGSI DIDISFRARG KAVSTVFDQD
Nsf TSPNHKYIFT LRTHPSWPG SVAFSLPQRK WAGLSIGQEI EV...ALYSF DKAKQCIGTM TIEIDFLQKK NIDSNPYDTD
C_Secl8p ELVALFLKNY ENQILQPTQV IYMEYTGIYF QIRVNNVQII DVNTKDQLPS FKDSDDINTK GILIKSTDVG FYPYEGSIIN
Secl8p ELAKQFVRCY ESQIFSPTQY LIMEFQGHFF DLKIRNVQAI DLGDIE..PT SAVATGIETK GILTKQTQIN FFKGRDGLVN
Nsf KMAAEFIQQF NNQAFSVGQQ LVFSFNDKLF GLLVKDIEAM DPSILKGEPA SGKRQKIEV. GLWGNSQVA FEKAENSSLN
C_Secl8p LTKPKTLKQR MFGGSTPHRT SRRKQIINPD FKLEDLGIGG LDAEFQDIFR RAFNSRILPP ELAEKLDYKH CKGLLLYGPP
Secl8p LKSSNSLR PRSNAVIRPD FKFEDLGVGG LDKEFTKIFR RAFASRIFPP SVIEKLGISH VKGLLLYGPP
Nsf LIGKAKTKE NRQSIINPD WNFEKMGIGG LDKEFSDIFR RAFASRVFPP EIVEQMGCKH VKGILLYGPP
C_Sec18p GTGKTLIARK LSKMLNGKEP KIVNGPEMLS KYVGASEENI RNLFKDAEAE YKLKGEDSDL HVIIFDELDS VFKQRGSGKS
Secl8p GTGKTLIARK IGTMLNAKEP KIVNGPEILS KYVGSSEENI RNLFKDAEAE YRAKGEESSL HIIIFDELDS VFKQRGS.RG
Nsf GCGKTLLARQ IGKMLNAREP KWNGPEILN KYVGESEANI RKLFADAEEE QRRLGANSGL HIIIFDEIDA ICKQRGS.MA
C_Secl8p DGTGVGDNW NQLLSKMDGV DQLNNILVIG NflfjRLDLIDT ALLRPGRFEI QIEISLPDEK GRKDIFLIHT KKLTENGILS
Secl8p DGTGVGDNW NQLLAKMDGV DQLNNILVIG b
Nsf GSTGVHDTW NQLLSKIDGV EQLNNILVIG NfTK
RKDLIDS ALLRPGRFEV QVEIHLPDEK GRLQIFDIQT KKMRENNNMS
RPDLIDE ALLRPGRLEV KMEIGLPDEK GRLQILHIHT ARMRGHQLLS
C_Secl8p SDVNFDELST LTKNFTGAEI EGLCNSAKSY AISRHTKKG. ALAQIDPESI AKMKITRDDF LLAL.NDIRP AFGTDEEDLS
Secl8p DDVNLAELAA LTKNFSGAEI EGLVKSASSF AINKTVNIGK GATKLNTKDI AKLKVTREDF LNAL.NDVTP AFGISEEDLK
Nsf ADVDIKELAV ETKNFSGAEL EGLVRAAQST AMNRHIK.AS TKVEVDMEKA ESLQVTRGDF LASLENDIKP AFGTNQEDYA
C_Secl8p QQAQHGIIQF NQTIRNIFEK GQSIIDWRS SETEHLRSIL LYGPPGVGKT SIATTLALNS DFPFIKMLSA ETLVGMGELR
• • • ••• ••• •••••• • ••••••• • ••••
Secl8p TCVEGGMMLY SERVNSILKN GARYVRQVRE SDKSRLVSLL IHGPAGSGKT ALAAEIALKS GFPFIRLISP NELSGMSESA
Nsf SYIMNGIIKW GDPVTRVLDD GELLVQQTKN SDRTPLVSVL LEGPPHSGKT ALAAKIAEES NFPFIKICSP DKMIGFSETA
C_Secl8p KIQEIDNVFR DVHKSPLNVL VIDKIENIIN YNPIGPRFSN DILQVLMVYL TKKPPKGRRL LIIGTTSQYQ VFKHMNLIDS
Secl8p KIAYIDNTFR DAYKSPLNIL VIDSLETLVD WVPIGPRFSN NILQMLKVAL KRKPPQDRRL LIMTTTSAYS VLQQMDILSC
Nsf KCQAMKKIFD DAYKSQLSCV WDDIERLLD YVPIGPRFSN LVLQALLVLL KKAPPQGRKL LIIGTTSRKD VLQEMEMLNA
C_Secl8p FNDAIAVPPI KHIEEVGKVL DKLGFMNKSE REEILSQLSR Y..DINIGIK SLIDVLMVS. .KYSRDTVDE WNNIVEKMS G
Secl8p FDNEIAVPNM TNLDELNNVM IESNFLDDAG RVKVINELSR SCPNFNVGIK KTLTNIETA. .RHDEDPVNE LVELMTQSA
Nsf FSTTIHVPNI ATGEQLLEAL ELLGNFKDKE RTTIAQQVK. .GKKVWIGIK KLLMLIEMSL QMDPEYRVRK FLALLREEGA SPLDFD
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Figure 4.6 The predicted secondary structure of the protein
encoded by the mutant allele SEC18-109
A secondary stucture prediction of the region containing the single amino acid
mutation Thr394 to Pro was undertaken using a combination of several seperate
methods. Combined predictions for a-helix (bottom), (3-sheet (centre) and
reverse turn (top) for (a) the wild-type Seel8p and (b) the DNM mutant
Secl8p are shown. The vertical axis represents the number of seperate
predictions for each structural element and the horizontal axis gives the residue
number over a 250 amino acid stretch of the protein around the mutation of
interest (see Figure 4.3. The horizontal lines represent the predicted
structural feature from the eight seperate predictions (J). * denotes the region
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Chapter 5
Characterization of the dominant negative
forms of the Secl8p
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5.1 Introduction
Using a screen based upon lack of colony growth on galactose selective medium 5
DNM alleles of the SEC18 gene have been isolated and named SEC18-108, 109,
110, 111 and 112 (see Chapter 4). To classify these mutants a number of specific
approaches were employed using a range of biochemical and morphological
techniques.
5.2 Biochemical Analysis
5.2.1 Growth of mutants
Growth was monitored for a wild-type yeast strain harbouring an extra copy of the
SEC18 gene under control of the GAL1 promoter, JRY188(pCH7) and for five yeast
strains each harbouring a mutant copy of the SEC18 gene under control of the GAL1
promoter, JRY188(pCH8 to pCH12). Yeast cultures were initially grown in a
glycerol / ethanol based selective medium followed by an additional 20hrs in a
galactose based medium which induces the expression of the DNM form of the
Secl8p. As can be seen in Figure 5.1. the growth of the wild-type yeast strain is
stimulated in the presence of galactose however growth is inhibited under similar
conditions in cultures of yeast that harbour a DNM form of the SEC18 gene. This
inhibition in growth varies for each yeast strain; yeast strains JRY188(pCH8, 9, 10
and 12) show the most severe growth defect, whereas the strain JRY188(pCHl 1)
shows a milder growth defect.
5.2.2 Secretory phenotype of the mutants
To confirm that the DNM forms of the Secl8p are affecting the secretory pathway of
the yeast cells, secretion of the bacterial protein p-lactamase (expressed from the
plasmid pYJS50) was monitored within the strain, JRY188(pCH7) and 5 mutant
yeast strains, JRY188(pCH8 to 12), over a 12hr time course, p-lactamase has been
shown to be correctly processed within yeast cells and by looking at the relative levels
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of activity both internally and externally has been shown to be correctly secreted from
yeast cells into the external medium (per. comm. A. Boyd). From repeated
quantification of internal and external (3-lactamase activities in these strains the
dominant negative mutant forms of the SEC18 gene can be classified into two main
groups; Class I mutants (SEC18-108, 109, 110 and 111 mutant alleles carried on the
plasmids pCH8, 9, 10, 11 ) show a decrease in the growth rate of the yeast culture
and an internal accumulation of p-lactamase when grown in galactose medium and
Class EI mutant (SEC18-112 mutant allele carried on the plasmid pCH12) which
shows a decrease in growth rate of the yeast culture but no internal accumulation of (3-
lactamase when grown in galactose medium.
The results represented in Figure 5.2 show p-lactamase activities obtained for a
typical Class I mutant (representative of the group) and a Class II mutant strain;
JRY188(pCH9) and JRY188(pCH12) respectively. This data is compared to that of
the wild-type strain JRY188(pCH7). The internal P-lactamase activity is represented
as a percentage of the total activity present and is normalised with respect to the
growth of each strain. The Class I mutant strain shows an internal accumulation of p-
lactamase activity, accumulating 20% of total P-lactamase activity internally after 10
hours of growth on galactose-containing medium. This suggests that the dominant
negative form of the Secl8p produced in this mutant may be interfering with the
normal secretion of P-lactamase from the cell.
The phenotype exhibited by the Class II mutant is consistent with a growth defect but
does not accumulate internal P-lactamase activity and so is not consistent with a
classical secretory defect at this point of the analysis. From the actual data (see
Table 5.1) it is apparent that Class I and Class II mutants have a decreased growth
rate on galactose medium which results in a decrease in the external P-lactamase
activity in both cases compared with that of the wild-type strain, JRY188(pCH7).
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However, unlike a Class I mutant the Class II mutant does not have a corresponding
increase in internal P-lactamase levels due to this imposed block on the secretory
pathway. This lack of internal accumulation of p-lactamase activity is not thought to
be due to incorrect processing of the prepro-af-p-lactamase basec on previous work
which showed that this precursor is still active (internally and externally) in a kex2
mutant strain ( per. comm. A. Boyd). However the lack of internal activity could be
due to mislocalization of p-lactamase as it is transported through the secretory
pathway to an environment, such as the yeast vacuole, in which it may be degraded.
5.2.3 Density increase of the mutants
If one assumes that the secretory pathway is being blocked by the action of the mutant
form of Secl8p within each class ofmutants the subsequent internal build up of
proteins and membranes should increase the density of the yeast cell. Such density
enrichment experiments were used in the identification of the original sec mutants
(Novick et al., 1980) and can be used to confirm the secretory phenotype of the two
classes ofmutants within this study.
As can be seen in Figure 5.3. the control yeast strain, JRY188(pCH7), expressing
wild-type Secl8p does not show a significant increase in cell density when grown in
galactose medium. However yeast strains expressing Class I (expressed from
plasmids pCH8 to 11) or Class II (expressed from plasmid pCH12) mutant forms of
the Secl8p show an increase in density when grown in galactose medium compared
to that observed when they are grown in raffxnose medium. In both types ofmutants
the growth of the strain is blocked when grown on galactose medium resulting in an
internal build up of proteins and/or membranes which leads to an increase in density
of the cells. Is this density shift similar for both classes of mutants? Fractionation of
the control wild-type (JRY188(pCH7)) gradient and also a Class I mutant (pCH9) and
a Class II mutant (pCH12) gradient was done to address this point (Figure 5.4).
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Compared with the wild-type fractionation pattern (Figure 5.4(a)) both classes of
mutants show a significant increase in cell density {Figure 5.4(b) and (c)) when
grown in galactose medium. But the density increase observed for the Class II mutant
is slightly less than that observed for the Class I mutant.
5.2.4 Internal processing of carboxypeptidase Y (CPY)
Secl8p has been shown to be involved at several stages of the secretory pathway
mediating vesicle docking/fusion events. At which stage of this pathway are the two
classes of dominant negative mutants blocking? The processing of the soluble
vacuolar glycoprotein CPY and secreted a-factor has been characterised in the
sec!8-l ts mutant strain both at the permissive and restrictive temperature by
following their oligosaccharide modifications and processing in the ER, Golgi
complex, and the vacuole (for CPY) as described in Chapter 1. Secl8p is required
for transport (and therefore processing) of the 67 kDa pi form of CPY from the ER
and also through the yeast Golgi compartments as the 69 kDa p2 form. Sec 18p
apparently is not involved in delivery of CPY to the vacuole, where it undergoes final
processing to the 61 kDa mCPY form (Stevens et al., 1982). In the absence of
polyclonal antibodies against a-factor the processing of CPY was followed in both
the Class I and Class II mutants grown in galactose medium and compared with that
observed in the strain JRY188(pCH7). The control strain BJ464a was used to
identify the p2 form of CPY as it is a pep4 strain which is deficient in proteinase B
and therefore cannot cleave the p2 form of CPY to its final mature form in the vacuole
and so accumulates the p2 form of CPY
Figure 5.5(a) shows the internal accumulation of the mature form of CPY over a
5hr time course in the wild-type yeast strain JRY188(pCH7) due to the continued
transport and processing of newly synthesised CPY through the secretory pathway
en route to the vacuole. As shown in Figure 5.5(b) the Class I mutant shows an
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internal accumulation of the pi form of CPY and a dramatic increase in the levels of
the p2 form of CPY. There does not seem to be a corresponding accumulation of the
mature form of CPY in this mutant. The accumulation of the pi and p2 forms of CPY
can be observed after only 5 hours of growth on galactose-containing medium This is
consistent with a model in which the dominant negative form of the Secl8p is
interfering with the function of the wild-type Secl8p in mediating vesicle
docking/fusion events between the ER and c/sGolgi (hence the build up of the pi
form of CPY) or between the Golgi and vacuole (hence the build up of the p2 form of
CPY). In contrast, in the Class II mutant, Figure 5.5(c), mature CPY continues to
accumulate, but there is only a modest accumulation of p2 CPY, and apparently no
accumulation of the pi form of CPY.
5.3 Morphological Analysis
5.3.1 Electron Microscopy: Internal membranes
Study of the sec18-1 ts mutant at the restrictive temperature under the electron
microscope reveals an internal accumulation of ER membranes and the presence of 50
nm vesicles (Novick and Schekman, 1979). The wild-type yeast strain
JRY188(pCH7), Class I and Class II mutant strains, JRY188(pCH8 to 11) and
JRY188(pCH12) respectively were examined by thin-section electron microscopy
(EM), using the stain uranyl acetate which specifically binds to membranes within the
cell (see Materials and Methods) and the strains were grown (a) in glycerol / ethanol
selective medium until early exponential phase of growth at which point 3% (w/v)
galactose was added and the cells were grown at 25°C over a 5hr time course with
samples being taken at Ohr, lhr, 3hr and 5hr time points after galactose addition to the
medium or (b) in galactose medium at 25°C for an extended period (20hrs) to obtain
the terminal phenotype of the mutants. The control mutant strain CHY01 was also
analysed by EM over a similar 5hr time course of growth at the restrictive temperature
of 37°C although a terminal phenotype was not done for this strain.
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The electron micrographs of the wild-type yeast strain JRY188(pCH7) show the
presence of large extended mitochodria within the cells due to their anaerobic growth
on glycerol / ethanol medium. Both the nucleus and vacuole(s) are distinguishable
within these cells as is the distribution of the ER which is closely associated with the
inner surface of the plasma membrane (as shown in Figure 5.6(a) ). Within the ts
secl8-l mutant strain CHY01 however there appears to be an internal accumulation of
extended ER tubules which line the inner surface of the plasma membrane and wind
through the cytoplasm of the cell. This internal accumulation of membranes seems to
become prominent after 3hr of growth at the restrictive temperature of 37°C (as
shown in Figure 5.6 (b)).
The Class I mutant strain JRY188(pCH9) displays a normal intracellular morphology
after 1 hr of growth on galactose media compared with that of the wild-type strain
JRY188(pCH7). However, after 3hr of growth on galactose media this mutant
accumulates extensive membranes (probably ER) that wind throughout the cell
cytoplasm similar to that observed within the ts strain CHY01. After 5hr growth on
galactose medium this mutant exhibits a highly tubular network of ER which is
present at the inner surface of the plasma membrane and throughout the cytoplasm
where multiple connections with the nuclear membrane are seen (see Figure 5.6(c))
The Class II mutant strain JRY188(pCH12) does not seem to have any obvious
membrane defects, compared to the wild-type strain JRY188(pCH7), when grown for
5 hr on galactose medium as shown in the electron micrographs in Figure 5.6(d)
yet these cells have been shown to arrest on galactose medium (see section 5.2.1.).
Does the Class II mutant have any obvious phenotype under the electron microscope
when grown for a longer period in galactose medium?
Figure 5.7(a) shows the terminal phenotype of the strain JRY188(pCH7) after 20hr
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growth on galactose medium. The cells contain one or two large vacuolar structures
and a large nucleus as depicted in Figure 5.7(a). The Class I mutant strain shows
extensive accumulation of internal membranes (probably extended ER) and also a
large number of small vacuolar structures as shown in Figure 5.7(b). In both cases
the terminal phenotype is representative of that seen in the earlier time course of
growth on galactose medium. However, there is an obvious phenotype in the Class II
mutant after 20hr growth on galactose medium which is not seen at an earlier growth
stage (see Figure 5.7(c)). The Class II mutant cells are very distorted; a number of
cells have not undergone septation and have multiple bud growths; many appear to
have abnormally thick cell wall deposition and most cells do not contain a clear
internal vacuolar structure. It is therefore apparent that the Class II mutant is defective
in cell secretion or cell wall deposition but there is not a clear internal membrane
abnormality as in the case of the sec mutants that can be seen at the electron
microscopic level.
5.4 Conclusion
In this chapter I have described aspects of the phenotypes resulting from the DNM
forms of Secl8p being expressed within yeast cells. Yeast cells producing a Class I
mutant form of Secl8p show an arrest of growth after 10 hrs of incubation on
galactose-containing medium and a corresponding increase in cell density. The
SEC18 gene has been shown to participate in vesiclular trafficking events throughout
the secretory and endocytotic pathways, mediating vesicle fusion events. The
secretion of p-lactamase from cells expressing a Class I mutant allele was monitored
to find the point at which the mutant peptide may be interfering in secretion. It was
found that on arrest of growth the Class I mutant accumulated approximately 20% of
the total p-lactamase activity within the cells. This suggests that secretion of P-
lactamase is being retarded but not completely blocked. The processing of the
vacuolar protein CPY was also monitored an shifting mutant cells to medium
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containing galactose. After only 5 hours of growth on this medium there was an
increase in both the pi form (ER) and to a greater extent the p2 form (Golgi) of CPY.
The processing of CPY within this mutant seems to be affected at an earlier stage of
growth and to a greater extent than secretion of [3-lactamase suggesting that the
trafficking of CPY to the vacuole is being blocked in these mutants. Although no
evidence has suggested that Secl8p is involved in vesicle trafficking to the vacuole it
is thought to be involved at vesicle fusion events within the secretory and endocytotic
pathways within yeast cells. The Class I DNM protein could therefore in theory
interfere in membrane trafficking within yeast cells at various stages. A possible
vacuolar defect may be implied within these cells from the EM analysis particularly
after 20 hours of growth on galactose-containing medium. Wild-type cells all show a
large vacuole-like structure whereas the Class I mutant has both a large accumulation
of internal membranes and a number of small aberrant vacuolar-like stuctures.
The Class II mutant does interfere with the growth of the yeast cells but does not
appear to cause an internal accumulation of [3-lactamase activity or precursor forms of
CPY. However, expression of the Class II mutant does produce an increase in the
density of the yeast cells compared to the wild-type strain JRY188(pCH7).
Morphological analysis has also shown that this mutant has an unusual terminal
phenotype in that the cells are obviously defective in there shape and again they
contain a number of small aberrant vacuolar-like structures seen under thin-section
electron microscopy compared with that of the wild-type cell.
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Figure 5.1 Growth of mutants upon shifting to galactose medium
Yeast strains JRY188(pCH7) and JRY188(pCH8 to pCH12) were grown overnight at
25°C in a glycerol/ethanol based medium until the O.D600 was approximately 0.2.
The O.D60o was monitored for a further 4hrs in this medium at which point 3% (w/v)
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Figure 5.2. Assay of (5-lactamase activity secreted from both wild-
type and mutant yeast strains.
Yeast strains JRY188(pCH7) and JRY188(pCH8 to 12) were transformed with the
plasmid pYJS50 (carrying a prepro-af-(3-lactamase fusion gene under the control of
the a-factor promoter and the LEU2 selective marker) which constitutively expresses
the bacterial enzyme P-lactamase. These transformants were grown in 200ml cultures
of 3% glycerol/ethanol selective medium overnight at 25°C until the O.D60o was
approximately 0.2 (to). After 2hrs of growth at 25°C, galactose was added to a final
concentration of 3% (w/v) and the cultures grown for a further lOhrs. Duplicate 5ml
samples were removed from each culture at to, t2, t4, t6, t8, t10, and t12 and the
O.D600 measured. Each aliquot was centrifuged at 5,000 rpm for 5 min to pellet the
yeast cells and the external medium was retained. The (3-lactamase activity was
measured in a low speed supernatant (S3), prepared from a glass bead homogenate,
containing 0.1% (v/v)Triton X100 and termed the internal P-lactamase activity . The
P-lactamase activity was also measured in the external medium (see Materials and
Methods). The internal p-lactamase activity was measured as a fraction of the total P-
lactamase activity present. The two graphs presented are representative of results
obtained for Class I and Class II mutants and are compared to that of the strain
JRY188(pCH7):
GRAPH (a) : Internal accumulation of P-lactamase observed for Class I mutants
compared with the strain JRY188(pCH7).
GRAPH (b): Internal P-lactamase activity observed for the Class II mutant
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Table 5.1. Internal and external (3-lactamase activity within a Class I
and Class II mutant. This table presents two sets of data comparing internal and
external levels of (3-lactamase activity. pCH71 represents control data for pCH9 and
pCH72 represents control data for pCH12 in individual experiments.
Time pCH7j pCH9 pCH72 pCH12
(hrs) Int Ext Int Ext Int Ext Int Ext
0 .027 .707 .119 .970 .012 .555 .012 .542
2 .021 .817 .146 1.45 .016 .989 .018 .956
4 .044 1.43 .162 2.84 .030 1.09 .039 1.31
6 .035 1.53 .227 2.39 .013 1.22 .023 1.01
8 .063 3.02 .271 1.82 .029 1.09 .018 .910
10 .056 2.12 .252 1.66 .049 1.39 .035 1.04
12 .058 2.29 .367 1.55 .064 1.48 .024 .750
KEY: Int - internal p-lactamase activity (AA490 per min per ml per OD600)
Ext - external p-lactamase activity (AA490 per min per ml per OD600)
pCH7 - Yeast strain JRY188(pCH7)
pCH9 - Yeast strain JRY188(pCH9)
pCH12 - Yeast strain JRY188(pCH12)
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Figure 5.3. Density enrichment of mutant strains grown on galactose
medium.
The yeast strains JRY188(pCH7) and JRY188(pCH8 to 12) were grown in 10ml of
raffinose selective medium at 25°C until the OD 60o was 0.2. The cultures were split
into two 5ml cultures (A and B) and galactose was added into culture B to a final
concentration of 2% (w/v). These cultures were grown for a further 5hrs at 25°C at
which point the cells were pelleted by centrifugation at 5,000rpm for 5 min. The cell
pellets were resuspended in 500|ll of 10% Percoll, lxTE (10 mM Tris.HCl pH7.4, 1
mM EDTA pH8.0). This 'yeast cell suspension' was layered on top of a 20 - 100%
Percoll/lxTE continuous gradient (10ml) then overlayed with 500|il of lxTE buffer as
shown in (a). The gradients were centrifuged at 2,000rpm for lOmin at room
temperature. The distance from the top of the gradient to the middle of each yeast
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Figure 5.4. Fractionation of density gradients.
The gradients from yeast transformants JRY188(pCH7), JRY188(pCH9) and
JRY188(pCH12) grown in raffinose (-GAL) or galactose (+GAL) medium were
fractionated by puncturing the bottom of the tube containing the gradient and pumping
twenty 0.5ml fractions from the gradient. The O.D600 was recorded for each fraction
and is shown on the following graphs:
GRAPH (a) : Control gradient showing a nonsignificant density shift of wild-type
yeast JRY188(pCH7) when grown in galactose medium.
GRAPH (b) : Density shift observed for a Class I mutant -JRY188 (pCH9), in
galactose medium.
















































Figure 5.5. Western blot analysis of carboxypeptidase Y (CPY)
processing within both wild-type and mutant yeast strains.
The yeast strains JRY188(pCH7), JRY188(pCH9) and JRY188(pCH12) were
innoculated into a 150ml culture of glycerol/ethanol based selective medium which
was grown overnight at 25°C until the O.D60o was approximately 0.5 (to). Galactose
was then added to a final concentration of 3%(w/v) and the cultures were grown for a
further 5hrs. 20ml samples were removed from these cultures at t1? t3, and t5 from
which a low speed supernatant (S3) was prepared from a glass bead homogenate and
resuspended in a final volume of 50|il. 15(il of each sample was loaded onto a 10%
SDS polyacrylamide gel (containing a 3:1 ratio of acrylamide : bis acrylamide). CPY
was detected by Western blot analysis using an affinity purified primary rabbit anti-
CPY polyclonal antibody at a 1:100 dilution overnight. The blot was then incubated
with a second donkey anti-rabbit HRP conjugate polyclonal antibody at a 1:5,000
dilution for 20 min and detection was done using ECL.
GEL (a) : LANE 1 to 4 contain S3 samples of strain JRY188(pCH7) at time points
to, t!,t3 and t5.
GEL (b) : LANE 1 to 4 contain S3 samples of strain JRY188(pCH9) at time points
to, tj, t3 and t5.
GEL (c) : LANE 1 to 4 contain S3 samples of strain JRY188(pCH12) at time
points to, t1? t3 and t5.
LANE 5 in each gel contains an S3 extract from the 'terminal' time point of 20hr (t2o)-
LANE 6 in each gel contains an S3 extract from the strain BJ464a showing the p2
form of CPY.
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Figure 5.6. Electron micrographs of wild-type and mutant yeast
strains over a 5 hour time course of growth on galactose medium or at
3 7°C.
The yeast strains JRY188(pCH7), JRY188(pCH9) and JRY188(pCH12) were grown
overnight in 200ml culture volumes of 3% glycerol/ethanol selective media at 25°C to
a starting O.D600 of approximately 0.2. A 50ml sample was removed (to) and
galactose was added to a final concentration of 3%(w/v). The cultures were then
grown for a further 5 hrs at 25°C with 50ml samples removed at t1;t3 and t5. These
aliquots of cells were immediately fixed in solution and the cells prepared for electron
microscopy after staining in uranyl acetate as described in Materials and Methods.
The yeast strain CHY01 was also monitored over a 5hr growth period during a shift
to the restrictive temperature of 37°C. The resultant electron micrographs are
represented below for .„e four time points (to, t1? t3, and t5):
(a) Electron micrographs of wild-type strain JRY188(pCH7).
(b) Electron micrographs of control strain CHY01.
(c) Electron micrographs of a Class I mutant strain JRY188(pCH9)
(d) Electron micrographs of a Class II mutant strain JRY188(pCH12).
All electron micrographs were taken at a magnification between 13K and 20K.
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Figure 5.6 (a)


























Figure 5.7 Electron micrographs of wild-type and mutant yeast
strains showing their terminal phenotype after 20 hours of growth on
galactose medium.
The yeast strains JRY188(pCH7) and JRY188(pCH8 to 12) were grown at 25°C
overnight in 100ml 3% glycerol / ethanol selective medium to a starting O.D600 of 0.1
to 0.2. Growth of these cultures was monitored for 4hrs at 25°C then galactose was
added to a final concentration of 3%(w/v) and growth was monitored for a further
20hrs at 25°C. These yeast cultures were then immediately fixed and prepared for
electron microscopy as described in Materials and Methods. The resultant
micrographs are as below:
(a) Electron micrograph of wild-type yeast strain JRY188(pCH7)
(b) Electron micrograph of Class I mutant strain JRY188(pCH9)
(c) Electron micrograph of Class II mutant strain JRY188(pCH12)




Isolation of galactose-resistant revertants of strains
harbouring dominant negative SEC18 mutations
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6.1 Introduction
The construction and isolation of dominant negative mutant forms of the SEC18
gene has been described in Chapter 4. To try and identify genes (and ultimately
proteins) which interact with the SEC18 gene the isolation of suppressors of these
mutants was undertaken. This type of genetic screen is one in which the parental
mutation (the DNM form of the SEC18 gene) and the suppressor mutation alter sites
of mutual protein / protein interaction. The parental mutation destroys or distorts
this protein interaction and the suppressor mutation produces a compensating
alteration that restores the interaction. An intragenic suppressor produces a
compensating alteration in the parental protein itself whereas an extragenic
suppressor produces a compensating alteration in another protein that is in physical
contact with the parental protein. Suppressor analysis is particularly useful for
investigating proteins that engage in strong non-covalent interactions with one
another (Moya et al., 1993). Since Secl8p is thought to be involved in a protein
complex the isolation of extragenic suppressors seems a good approach to identify
interacting proteins. A genetic interaction has previously been shown between the
SEC18 gene and the SEC17 gene and may be used to validate the approach taken
within this genetic screen.
6.2 Isolation of suppressors of the DNM forms of the SEC18 gene
The five dominant negative mutant forms of the Secl8p confer a secretory defect in
the yeast S. cerevisiae in vivo which is shown as conditional lethality on galactose
medium (see Chapter 4). Spontaneous suppressors or suppressors obtained by
using a mutagen that overcome the original mutation can then be isolated such that
the strain regains the ability to grow on galactose medium. For this study both
untreated and chemically mutagenised cells (using the mutagen methanesulphonic
acid ethyl ester, EMS) were used in attempts to isolate suppressors of the original
mutations. Obviously, this mutagenic procedure may simply produce further
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mutations in the DNM form of the SEC18 gene which compensate for or reverse the
original mutation (intragenic suppressors) and so secretion will occur as normal. To
minimise this, so favouring the isolation of extragenic suppressors, yeast strains
containing two copies of the DNM form of the SEC18 gene (one copy being carried
on a centromeric based plasmid and the other being integrated into the genome)
(.Figure 6.1) were used in the mutagenic procedure.
The extra copy of the DNM SEC18 gene was integrated into the genome of the
yeast strain JRY188 at the URA3 locus. The ura3-52 allele within this yeast strain
is caused by an insertion of the transposable (Ty) element within the coding region
of the URA3 gene (Rose and Winston, 1984). Following integrative
transformation these strains were shown to have a mutant phenotype of conditional
lethality when grown on galactose selective medium and the disruption of thcura3-
52 allele was verified by Southern blot analysis (Figure 6.2). Although some
integrated strains don't show all the expected fragments on Southern blot analysis,
each integrated strain has a mutant phenotype of lack of growth on galactose
medium. These strains were named CHY02 to CHY06 respectively.
The yeast strains CHY02 to CHY06 were then transformed with the corresponding
DNM form of the SEC18 gene carried on the plasmids pCH8 to pCH12 thus
creating strains which have two copies of the DNM form of the SEC18 gene: these
strains were named CHY02(pCH8) to CHY06(pCH12) respectively. Initial studies
were undertaken to isolate suppressors of two of these mutant strains
CHY03(pCH9) and CHY06(pCH12) which express mutant forms of the Secl8p
that have been characterized to the greatest extent (see Chapters 4 and 5) and
represent a Class I and Class II mutant respectively. Both of these strains were
chemically mutagenised (see Materials and Methods) and then after a recovery
period were plated out onto galactose selective plates. It was hoped that any
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colonies that grew on galactose would contain a suppressormutation in a novel
gene encoding an altered protein that could compensate for the initial dominant
negative mutation.
To identify the gene in which this suppressor mutation lies two possible approaches
were considered; (a) A secondary phenotype conferred by the suppressor mutation
could be identified such as cold or temperature sensitivity. Rescue of this secondary
phenotype by a wild-type yeast expression library would then identify the wild-type
copy of the original suppressor allele, (b) Alternatively, in the absence of a
secondary phenotype a genomic library may be constructed from the suppressor
strains so identifying the suppressor allele directly. The latter approach was taken in
this work.
A number of revertants of both strains were isolated (>100) and named
CHY02/Sx(pCH9) and CHY06/Sx(pCH12) where x=number of suppressor.
These strains could harbour either dominant or recessive suppressor mutations.
Since a large number of suppressors were isolated I decided that rather than
construct individual genomic libraries for each suppressor a pooled genomic library
would be a more reasonable approach. This approach also favours the identification
of dominant suppressor alleles. The construction of an initial genomic library
however was attempted in order to optimise the techniques involved. Unfortunately
problems arose in the construction of this library and so I will describe the
approaches taken in constructing such a library. These attempts were, however,
ultimately unsuccessful.
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6.3 Large scale purification and size fractionation of yeast genomic
DNA (Rose et al., 1987)
The suppressor yeast strain CHY02/S72(pCH9) was grown overnight at 30°C in a
1L culture volume of YEPD medium. The yeast culture was centrifuged at 5,000
rpm for lOmin and the pellet was then washed in 500 mM EDTA pH7.5. The
resultant pellet was then resuspended in 5 ml of lysis buffer (0.1 M Tris.HCl
pH9.5, 0.15 M NaCl, 0.1 M EDTA, 2%(v/v) P-mercaptoethenol) and frozen in
liquid nitrogen for 15-30 min. This sample was then thawed and an additional
20 ml of lysis buffer pH9.5 and 4%(w/v) sarcosyl was added and incubated at
45°C for a further 20min. To this material 20 ml of lysis buffer pHS.O containing
4%(w/v) sarcosyl was added and incubated at 70°C for 15min. DNAse-free
RNAse was added to a final concentration of 0.1 mg/ml and the sample incubated at
45°C for lhr. Proteinase K was then added to a final concentration of 0.8 mg/ml
and the mixture was incubated at 37°C for 2 hrs, followed by incubation at 70°C
for 15min. This material was extracted twice with an equal volume of
phenol/chloroform mixture (24:1) and the upper aqueous layer extracted each time
after centrifugation at 10,000 rpm for 15min. This upper aqueous layer (containing
the DNA) was incubated at 45°C for 2.5hr to remove any traces of chloroform then
2X volume of 100% ethanol was added to precipitate the DNA. The DNA was
spooled from this mixture and resuspended in 10 ml of TE buffer. Solid CsCl was
added to this DNA solution to reach a final concentration of lg CsCl/0.8 ml. These
tubes were centrifuged at 50,000 rpm for 18hr at 15°C with no brake. The tubes
were perforated at the bottom and fractions collected. Fractions which contained
DNA were pooled and dialysed against TE buffer for 24hr and the concentration of
this DNA determined spectrophotometrically to be OTpg/pl then stored at -70°C.
Purified genomic DNA (l|ig) from the suppressor strain CHY02/S72(pCH9) was
partially digested with Sau3A initially using different concentrations of enzyme to
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optimise the digestions to yield fragments of genomic DNA of >10 kbp. Genomic
DNA was digested with 0.08U/|ig DNA up to 2U/|ig DNA at 37°C for lhour and
the best concentration of enzyme was found to be 0.08U Saw3A/mg DNA. This
was then scaled up for approximately 400|ig of genomic DNA which was digested
with 0.8U SauiA/mg DNA for lhr at 37°C. The digest was then extracted with
phenol/chloroform and the DNA was ethanol precipitated and resuspended in TE
buffer. This partially digested DNA was size fractionated on a preparative 10-40%
sucrose gradient (Ausubel et al., 1987). Fractions of 0.5ml were collected from the
bottom of these gradients and analysed for the presence ofDNA on a 0.4% agarose
gel (Figure 6.3). Fractions 4-7 were pooled to yield size fragments >10 kbp and
fractions 8 (8 kbp), 9 (5 kbp) were retained - these fractions were diluted, ethanol
precipitated and stored at 4°C.
6.4 Attempted construction of a yeast genomic DNA library
The vector YCplac22 was chosen as a low copy number plasmid to be used in
constructing the suppressor library. A centromeric based vector was chosen as it
had been shown that episomal plasmids carrying wild-type SEC18 suppressed the
dominant negative phenotype seen in yeast strains CHY02 and CHY06. It was
anticipated that the use of a centromeric based library would minimise the
occurrence of wild-type suppression of the dominant negative phenotype. The
vector YCplac22 was digested with BamHl then treated with calf intestine alkaline
phosphatase for 20 min at 37°C. Efficiency of phosphatase treatment was
monitored by comparing the efficiency of ligation of both untreated linearized vector
and dephosphorylated vector. A number of test ligations were done with varying
ratios of vector : insert concentrations and ligated overnight at 16°C. The bacterial
strain NM522 was initially used for transformation of these ligations using CaCl2
prepared competent cells which have a transformation efficiency of 105/|ig DNA
when prepared by this method.
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DNA was prepared from a number of transformants and digested to check the size
of the insert carried (Figure 6.4). However, as seen in Figure 6.4 it appears
that the digests are giving smaller fragments than the initial vector whereas one
would predict fragments of either the same size as the vector plus an insert fragment
or a linearised clone which represents the sum of the vector and insert fragment
sizes. The plasmid pCH14 which is integrated in the strain used contains an
ampicillin gene and the final library selection is also based on ampicillin. Could the
Sau3A partial digestion be digesting pCH14 and these smaller plasmids are ligating
and are selected for in this protocol? To overcome this the KanR gene was cloned
from the plasmid pCXJKan-1 into YCplac22 to give the resultant plasmid YCpKan-
1 (see Table A.4) thus allowing a final selection purely for this plasmid. The
ligations were repeated with this new vector and transformants selected on
kanamycin plates. However, on restriction enzyme analysis of the subsequent
clones these abnormal digest-patterns were still observed. Coupled to these
inexplicable clones that were being produced the transformation efficiency with the
strain NM522 was quite poor. Attempts were made to improve this efficiency both
by using different protocols in the preparation of the competent bacteria and using
commercially made 'library efficient' JM109 competent bacteria, however in both
these cases the efficiency was quite poor.
6.5 Conclusion
I have described in this Chapter the steps taken to isolate a number of suppressors
of the strains CHY03 (pCH9) and CHY06 (pCH12) to identify genes that interact
with the SEC18 gene. >100 suppressors of both these strains were isolated using
the chemical mutagen EMS. These suppressors may represent mutations in
protein(s) involved in a Secl8p complex, which may compensate for the dominant
negative form of the peptide. Mutation of the DNM Secl8p to a non-interacting
form of the protein may also suppress the mutant phenotype, although the increased
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copies of the DNM gene within these strains should decrease this likelihood.
Reversion of the DNM Secl8p to the wild-type peptide may also occur within these
strains and in theory the more copies of the DNM gene present the greater the
chance for this to occur. However in practice the probability of mutating a single
specific nucleotide so reverting the SEC18-109 allele to the wild-type gene is very
low. The DNM effect of Secl8p depends on the levels ofmutant peptide present
within the cell compared to that of the wild-type protein. Expression of both the
SEC18-109 and SEC18-112 genes is from the GAL1 promoter which is dependent
on activation by the GAL4 transcription factor. Therefore any mutations in the
GALA gene will affect the levels of GAL induction and so the amount ofDNM
protein produced within the yeast cells. Such strains which have a mutated GAL4
gene or GAL1 promoter may be identified by poor growth on galactose-containing
medium. However, within the time available for this work the gene(s) responsible
for these suppressors could not be isolated. This was mainly due to technical
problems arising in the construction of suppressor genomic libraries (as indicated in
this Chapter).
The fact that suppressors ofmy DNM SEC18 genes can be isolated indicates that
these mutants may be used with a number of alternative screens to isolate
suppressor genes. One such screen is based on an ADE2/ADE3 sectoring assay
(Koshland et al., 1985) and has recently been used to isolate the TIP I gene which
encodes a protein that interacts with Sec20p (Sweet and Pelham, 1993).
Alternatively, the isolation of multi-copy suppressors of the dominant negative gene
may be investigated. Multicopy suppression has been observed with some
frequency during attempts to clone genes by complementation, and in many cases
the genes identified in this way encode proteins that serve a related function or
interact with the original mutated gene product (Nakano and Muramatsu, 1989;
Burton et al., 1993).
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Figure 6.1 Integration of the DNM forms of the SEC18 gene into
the yeast genome by homologous recombination
The integrative plasmids YIplac211, pCH13, 14, 15, 16 and 17 were introduced
into the yeast strain JRY188 and were subsequently integrated at the ura3-52 allele
in vivo by homologous recombination. To stimulate recombination of these
plasmids at the URA3 locus they were digested with the restriction endonuclease
Stu\ which linearizes the plasmid in the URA3 gene. This results in the integration
of plasmids pCH13 to pCH17 between a recreated functional URA3 gene and a
nonfunctional ura3-52 allele in the genome. Resultant transformants are therefore
Ura+ and named CHY02 to CHY06. The restriction sites shown are Hindlll (H)
and Stul (S).
Digestion of wild-type yeast (JRY188) genomic DNA with Hindlll and
hybridization of an enzymatically labelled URA3 prode to this digested DNA should
produce two fragments on Southern analysis of predicted sizes: (4.15+x)kbp and
(l+y)kbp. Digestion of genomic DNA from SEC18 -108, 109, 110, 111 and 112
integrated strains however will produce three fragments of the predicted sizes:

















3.8kbp ( 7.57+y ) kbp
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Figure 6.2 Southern blot analysis of integrated strains
The yeast strains JRY188, CHY02 to CHY06 and CHY07 were grown overnight at
30°C in YEPD medium. A small scale preparation of total genomic DNA was made
from these strains and the control stain JRY188. This genomic DNA was digested
with Hindm and electrophoresed on a 0.8% agarose gel. The DNA was transferred
onto a nitrocellulose membrane and Southern analysis was performed using a
nonradiolabeled DNA probe. A representative blot is shown:
LANE 1: Genomic DNA from strain CiiY02
LANE 2: Genomic DNA from strain CE1Y03
LANE 3: Genomic DNA from strain CHY04
LANE 4: Markers-pBR 328 DNA digested separately with BamHl, Bgll and Hinfl
and mixed with each other in a ratio 2:3:3.
LANE 5: Genomic DNA from strain CHY05
LANE 6: Genomic DNA from strain CHY06
LANE 7: Genomic DNA from control strain JRY188
LANE 8: Genomic DNA from control strain CHY07
The probe used to detect the predicted DNA fragments from each strain was a 1.1
kbp URA3 fragment obtained as a BamHl cassette from the plasmid YDpU. This
probe was labelled with the non-radioactive label digoxigenin-ll-UTP (as described
in Materials and Methods). This probe will hybridise to the three fragments of
sizes; (4.15+x)kbp, 3.8kbp and (7.57+y)kbp in the SEC18 integrated strains and to
one main band of (l+y)kbp in the control strain JRY188. The marker DNA was
detected by a separate probe of digoxigenin-labelled linearized pBR328 DNA.
143
144
Figure 6.3 Size fractionation of partially digested yeast genomic
DNA
Partially digested yeast genomic DNA was fractionated on a 10-40% sucrose
gradient (as described in Materials and Methods) then the gradient was fractionated
from the bottom into approximately 20 fractions. 5 |ll of each 200 (ll fraction was
run on a 0.4% agarose gel and DNA was monitored in each fraction.
LANE 1 to 14: Fractions from the sucrose gradient from the bottom (lane 1) to the
top of the gradient (lanel4).
LANE 16: lkbp DNA ladder
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Figure 6.4 Restriction digest analysis of putative library clones
Putative genomic library clones were rescued from the transformed bacteria for
restriction enzyme digestion to find the average insert size obtained. 24 clones were
digested with £coRI and analysed on a 0.8% agarose gel as shown. 11 clones had
abnormal restriction digest patterns (*) and 6 clones did not contain a detectable
insert (x). 8 recombinant plasmids contained inserts but these were only







Intracellular membrane traffic is regulated by a number of mechanisms in order to
facilitate the correct and efficient transport of proteins from their site of synthesis to
their final destination. One of the intriguing questions posed over the last few years
has been how do membrane bilayers fuse with each other and what regulates these
fusion events in order to obtain targeting specificity. A combination of yeast genetics,
mammalian cell free systems and affinity purification techniques has been used to
answer some of these questions. Greatest progress has been achieved within
mammalian systems initially using in vitro assays which reconstituted vesicular
transport within the Golgi (see Chapter 1) apparatus. This system led to the
identification of soluble proteins which were required for fusion to occur (NSF and
SNAPs) which were further identified to be part of a complex of proteins which had a
sedimentation coefficient of a 20S particle. Subsequent purification of this 20S
particle from bovine brain material led to the identification of the individual
components of this fusogenic particle involved in the regulated release at the synaptic
cleft (see Chapter 1) and the finding that homologues of these proteins may act in a
similar manner within a number of constitutive fusion events conserved from yeast to
neuronal cells.
Within this work I have described the use of two approaches in the identification of
proteins which interact with the Secl8p (NSF homologue) in the budding yeast S.
cerevisiae. The first approach was a biochemical affinity purification procedure,
relying on a tagged version of the SeclSp. A fusion protein was constructed between
Secl8p and a portion of the bacterial protein, Protein A. This fusion protein was
shown to be active in vivo by its ability to complement a secl8-l ts mutation at the
restrictive temperature and a significant proportion of this hybrid protein fractionated
in a similar fashion to that reported for the wild-type protein in vivo. Isolation of this
SeclSpra fusion protein from yeast was achieved using the affinity of Protein A for
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IgG which is bound to a Sepharose column. However, isolation of proteins
complexed to this hybrid protein was unsuccessful. Firstly, the high background of
non-specific proteins from yeast extract which bound to the Pra tag of the fusion
protein was sufficient to mask the presence of any Secl8p-specific proteins within the
affinity purified material. Secondly, although Secl8p could be identified within
affinity purified material, using a polyclonal antibody raised against Secl8p, the
presence of Secl7p could not be shown (again using a Secl7p specific polyclonal
antibody). The lack of Secl7p within this material could be due to the small amounts
of fusogenic complex being isolated in the purification procedure and therefore
outwith the levels of detection employed within the assay. The presence of Secl8p
within the affinity purified material is encouraging as it shows that the fusion protein is
interacting with the wild-type protein. This interaction is not interfering with the
normal function of Secl8p within the fusogenic complex and its capacity to facilitate
vesicular transport in the secretory pathway. Therefore, I believe that an alternative
affinity purification procedure is still feasible from a yeast system but an alternative tag
should be used which does not show such non-specific binding of yeast proteins such
as the c-myc epitope (Sollner et al., 1993a) or dihydrofolate reductase (DHFR) tag
(Salama et al., 1993).
An alternative approach to that of trying to isolate complexes which have formed in
vivo is the use of an affinity column to isolate complexes in vitro as has recently been
reported for the affinity isolation of NSF complexing proteins from mammalian cells.
This approach relied on the production of bacterially-expressed fusion proteins (NSF
and a-SNAP) which were used to produce an affinity column for the purification of
complexing proteins from a membrane preparation from bovine brain (Sollner et al.,
1993a). The alternative approach to identify proteins that complex with Secl8p would
be to express a bacterial Seel 8 fusion protein which could then be used on an affinity
column to isolate complexing proteins. My initial studies have shown that a bacterially
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expressed Protein A tag still shows this non-specific binding of yeast proteins when
used in such an affinity column and so alternative tags should be looked at such as
GST fusions or His6 fusion constructs.
The second approach taken during the course of this work was a genetic approach to
try and identify genes which interact with SEC18 (apart from the SEC17 gene). The
Secl8p has been shown to contain two ATP binding sites but no other information has
been reported about the nature of the interactions of this tetrameric protein within the
proposed fusogenic complex. It was due to this lack of information that a random
mutagenic strategy was taken in order to create Dominant Negative Mutants of the
Secl8p. Mutagenesis was done using either an in vitro mutagenic PCR strategy or in
vivo using a bacterial mutD strain. Five DNM SEC18 genes were produced in this
way which were grouped into two classes of mutations according to a number of
biological and morphological criteria (see Chapter 5).
Class I mutants seem to interfere with secretion from yeast cells expressing the mutant
allele (SEC18-109 to -111). The mutant peptide seems to have an effect in slowing
down ER to Golgi transport which was shown by an internal accumulation of the pi
form of the vacuolar protein CPY and the appearance of ER-like membranes
throughout the cells. However, it was also noted that in cells expressing the SEC18-
109 mutant allele there was a large increase in the p2 form of CPY and the cells had
abnormal vacuolar-like structures when viewed by EM. This suggests that vacuolar
trafficking was also being affected within these cells. Analysis of CPY trafficking by
pulse chase labelling may give a more precise view of CPY transport within this
mutant.
The Class II mutant however does not have a build-up of secreted protein and only
shows a mutant morphology under the EM after a long period of expression in vivo.
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Obviously both classes ofmutants have a dominant effect in vivo over the wild-type
Secl8p in that the normal function of the Secl8p is impaired and secretion is blocked.
This impairment of function in vivo may be due to the mutant protein interacting with
the wild-type protein to form mixed tetramers which interact with other proteins in the
fusogenic complex to give non-functional complexes or the mutant protein may just
'mop up' the wild-type protein to form non-functional aggregates which cannot
interact further within a protein complex.
However what of the Class II mutant phenotype? The phenotype of the Class II
mutant does not seem to be consistent with a block imposed within the secretory
pathway (i.e. no internal build-up of secreted proteins, internal membranes or pi form
of CPY) yet cell growth is affected. One possibility is that the mutant form of Secl8p
may be interfering in the normal proof-reading mechanism of the fusion process thus
promoting non-specific fusions to occur and the mislocalization of proteins within the
secretory pathway. This may be shown by the absence of accumulated internal (3-
lactamase activity but the decrease in external activity suggesting that maybe (3-
lactamase is being degraded at some point within the pathway due to its mislocalization
or mislocalization of proteases to a compartment in which it resides.
To measure the types ofmutations gained by the two methods of mutagenesis a Class I
mutant resulting from the mutD strategy and the Class II mutant which underwent
PCR mutagenesis were sequenced and compared to that of the wild-type gene. On
resequencing of the wild-type SEC18 gene an extra codon was identified within the
sequence which has since been reported by another group and entered into EMBL data
library (Van der Aart., 1994). A higher percentage of mutations were incurred when
using the PCR based strategy of mutagenesis (0.5%) compared with that of the mutD
mutagenesis (0.04%). Surprisingly in both mutants no mutations were seen within
the proposed ATP binding sites. The Class I mutant has only one base change which
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results in the mutation of a highly conserved threonine residue to a proline, which
results in the loss of Secl8p function. The structural significance of this change is not
known although initial studies show no significant alteration to die secondary structure
of the protein (see Chapter 4).
A number of revertants, presumably containing suppressors of these DNMs were
created. Attempts to identify the genes responsible for this suppression were
unsuccessful due to a number of technical problems in the construction of genomic
libraries of the suppressors. In the absence of obtaining genomic libraries further
characterization of the suppressors to identify whether they are dominant or recessive
alleles could be undertaken. Each suppressor strain may be crossed to a standard
wild-type yeast strain (of opposite mating type). If the resultant diploid still
suppressed the DNM phenotype (i.e if the strain were GAL+) then the suppressor
gene would be dominant. Recessive alleles may be further sorted into
complementation groups. Ideally for this two sets of suppressors should be
produced, each in a strain of opposite mating type. Crossing two suppressors that
lead to a GAL+ diploid suggests that the initial mutation were in the same gene. If the
resulting diploid is galactose sensitive then the mutations are in different genes. In this
way an idea of how many individual recessive genes (complementation groups) are
present may be given.
Alternative strategies could be employed in future work to identify these suppressor
genes: (1) one could look for high copy suppressors of the DNM phenotype by
transforming the DNM strain with a high copy number yeast genomic library. (2) A
secondary suppressor phenotype such as cold or temperature sensitivity which was
linked to the suppressor phenotype could be isolated and this rescued again by a wild-
type yeast genomic library.
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Although proteins which interact with the Secl8p could not be identified within this
work the isolation of DNM forms of the SEC18 gene should allow the use of
alternative genetic strategies in the future to identify interacting suppressor genes. The
sequencing of these mutants has started to address the functional relevance of regions
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KEY:
end Al mutation: improves plasmid yield, especially from mini-preps.
A(lac-proAB) deletion: removes the lac operon and surrounding region including two genes involved
in proline biosynthesis. Most strains carry these deleted genes on an F' episome.
lacl^ mutation: results in overproduction of the lac repressor, minimizing the low level of lac
expression that occurs in uninduced wild-type cells.
lacZAM15 deletion: removes the amino-terminal a-peptide of p-galactosidase. Vectors that carry lac
selection have a gene that encodes this peptide and rescues the mutation by a-complementation.
recA strain: is recombinant deficient and has a reduced ability to rearrange cloned sequences.
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Table A.4. Plasmids constructed in this study
Construct Description
pKpra2 The plasmid pKpra was digested with EcoRl/BamHl
and ligated with two annealed oligonucleotides 5'AAT
TCTAATAACTCGAGC-3'and 5 '-GATTATTGAGCT
CGCTAG-3'. This deletes the BamHl site from the
original plasmid inserting two stop codons
TAA,TAA(**) and introducing aXhol site which
creates a//mdIII **Xhol Pra 'cassette'.
M13SEC18 The complete SEC18 gene was excised from the
plasmid pSEY8 as a 3.0 kbp ScaVHindUl fragment
and ligated into the plasmid pK18 which had been
digested with Hindi/Hindlll. The SEC 18 gene was
then excised from pK18 as a BamHl/Hindlll cassette
and ligated into the plasmid M13mpl8 which had
been digested with BamHI/Hindlll.
M13SEC75PRA A 0.46 kbp/Zmdlll/X'/zoI fragment from pKpra2 was
treated with Klenow giving a blunt ended fragment.
This fragment was ligated into M13SEC7S digested
with Fspl to produce the intermediate vector
M13SEC7SPRA.
YCpGAL The GAL1/10 promoter was excised from pBM150
as a 0.685kbp EcoRl/BamHl fragment and ligated
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into the corresponding sites in YCplac22.
YCpKan-1 The Kan-r gene was excised from pCXJKan-1 as a
1.3 kbp SalI fragment and ligated into YCplac22
which had been digested with Sail.
pCHl The SEC18pra fusion gene was excised from
M13S'£,C75pra as a 3.5kbpBamHl/Xhol fragment
and ligated into the yeast plasmid YCplac22 which
had been digested with BamHl/SaB.
pCH2 Same as for pCHl except recipient plasmid was
YCplacll2
pCH3 Same as for pCHl except recipient plasmid was
YCpGAL
pCH4 Same as for pCHl except recipient plasmid was
YEpGAL
pCH5 and pCH6 The plasmids YCpGAL and YEpGAL were digested
with BamHI/SaR and ligated to the two
oligonucleotides 5'-GATCAAAATGTCTCCA-3' and
5'-AGCTTGGAGACATTTT-3' which contain
BamHl/Hindlll cohesive ends and an ATG in the
correct reading frame to allow the expression of Pra
from the GAL1 promoter. The 0.46kbp//mdIII/X/zoI
fragment from pKpra2 was ligated into this partial
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ligation.
pCH7 The SEC18 gene was cloned as a BamHl/Hindlll
fragment from the vector pSEY8 into the
BamHl/HindTll sites of YCpGAL.
pCH7A The SEC18 gene was cloned as a BamHl/HindlU
fragment from the vector pSEY8 into the
BamHl/HindlU sites of YEpGAL.
pCH8, 9, 10, 11 and 12 Mutated SEC18 genes were excised as
BamHl/HindlU fragments and ligated into the
plasmid YCpGAL which had been previously
digested with BamHl/HindlU.
pCH13, 14, 15, 16 and 17 The GALSEC18 cassette was digested as an
EcoRl/Hindlll fragment from the corresponding
plasmids pCH8, 9, 10, 11 and 12 and ligated into the
EcoRlJHindlU sites of the vector YIplac211.
pCHl 8 A 0.85 kbp fragment of the SEC18 gene was digested
from the vector pSEY8 as aNruI/HindlU fragment
which was then Klenow-treated to give a
Nrul/[HindUI\ fragment. This fragment was ligated
into the vector pKpra which had been digested with
Smal.
pCH19 A 0.8kbp fragment of the SEC18 gene was excised as
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an [Aval\/Hael\\ fragment and ligated into the vector
pEX12 which had been digested with Smal.
pCH20 The two oligonucleotides 5' -CGGGATCCAC IT
CTTCCCACAAGGAAGTAGC-3' and 5'-CGGGA
TCCAAGCTTGTATATATGTATGTCGCGTAAGTAT
ATGCC-3' were used to amplify a 0.86 kbp fragment
of the SEC17 gene from yeast genomic DNA using
PCR. This fragment of SEC17 gene encodes all the
Secl7p sequence except the first 11 amino acids.
This fragment was cloned as a BamHl fragment into
the vector pAXl 1 which had previously been
digested with BamHl to produce an in frame
Sec 17pra fusion protein.
pCH21 The SEC17 gene was excised from pCH20 as a
BamHl fragment and ligated into the vector pEXl 1
which had been digested with BamHl to give a
SEC17 (3-galactosidase fusion gene.
pCH22 The two oligonucleotides 5'CGGGATCCGGCTGCC
TTTAATTGTTATTCTTTTCC-3' and 5'-CGGGATC
CAAGCTTGTATATATGTATGTCGCGTAAGTATA
TGCC-3' were used to amplify a 1.14 kbp full
length SEC17 gene using PCR. This fragment was
digested with BamHl/HindYll and cloned into the
corresponding sites in the vector YCplac22.
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pCH22A Same as for pCH22 except the recipient plasmid was
YEplacll2.
pCH23 A 1.4 kbp fragment was excised from the plasmid
pCH7 as a BamHl/Bsml cassette (N region) and
ligated into the plasmid pCH12 which had previously
been digested with BamHl/Bsml.
pCH24 A 0.75 kbp fragment was excised from the plasmid
pCH7 as aBsml/Nrul cassette (M region) and
ligated into the plasmid pCH12 which had previously
been digested with Bsml/Nrul.
pCH25 A 0.85 kbp fragment was excised from the plasmid
pCH7 as aNrul/Hindlll cassette (C region) and
ligated into the plasmid pCH12 which had previously
been digested with Nrul/Hindlll.
Within the above table the use of [] depicts that the restriction site has been treated with
the large fragment of DNA polymerase I (Klenow) which fills-in 3' recessed ends
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